1,3-oxazoles - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	1,3-oxazoles	go back to main search page
Accession:	CHEBI:46812	browse the term

show annotations for term's descendants Sort by:
Rat (797) Mouse (792) Human (786) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (797)

4-(ethoxymethylene)-2-phenyloxazol-5-one

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily A member 6

decreases expression

Oxazolone results in decreased expression of ABCA6 mRNA

NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530

G

abhydrolase domain containing 10, depalmitoylase

decreases expression

Oxazolone results in decreased expression of ABHD10 mRNA

NCBI chr11:55,081,273...55,095,044
Ensembl chr11:55,081,049...55,107,866

G

ADAM metallopeptidase with thrombospondin type 1 motif, 15

increases expression

Oxazolone results in increased expression of ADAMTS15 mRNA

NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249

G

adenylate cyclase 6

decreases expression

Oxazolone results in decreased expression of ADCY6 mRNA

NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754

G

adrenomedullin

increases expression

Oxazolone results in increased expression of ADM mRNA

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

akirin 2

increases expression

Oxazolone results in increased expression of AKIRIN2 mRNA

NCBI chr 5:49,108,231...49,122,566
Ensembl chr 5:49,108,220...49,122,568

G

aldo-keto reductase family 1, member C2

increases activity

Oxazolone results in increased activity of AKR1C2 promoter

NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764

G

ankyrin repeat domain 2

increases expression

Oxazolone results in increased expression of ANKRD2 mRNA

NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566

G

amine oxidase, copper containing 1

increases expression

Oxazolone results in increased expression of AOC1 mRNA

NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840

G

arginase 2

increases expression

Oxazolone results in increased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho GTPase activating protein 17

decreases expression

Oxazolone results in decreased expression of ARHGAP17 mRNA

NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

Oxazolone results in increased expression of ASNS mRNA

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423

G

activating transcription factor 2

increases expression

Oxazolone results in increased expression of ATF2 mRNA

NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236

G

activating transcription factor 3

increases expression

Oxazolone results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

Axl receptor tyrosine kinase

increases expression

Oxazolone results in increased expression of AXL mRNA

NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265

G

antizyme inhibitor 1

decreases expression

Oxazolone results in decreased expression of AZIN1 mRNA

NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578

G

BRISC and BRCA1 A complex member 2

increases expression

Oxazolone results in increased expression of BABAM2 mRNA

NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951

G

BCL2-associated transcription factor 1

decreases expression

Oxazolone results in decreased expression of BCLAF1 mRNA

NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832

G

bone morphogenetic protein 1

increases expression

Oxazolone results in increased expression of BMP1 mRNA

NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776

G

bone morphogenetic protein 7

decreases expression

Oxazolone results in decreased expression of BMP7 mRNA

NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788

G

BPI fold containing family A, member 2

decreases expression

Oxazolone results in decreased expression of BPIFA2 mRNA

NCBI chr 3:142,493,379...142,501,343
Ensembl chr 3:142,493,379...142,501,337

G

B-box and SPRY domain containing

increases expression

Oxazolone results in increased expression of BSPRY mRNA

NCBI chr 5:75,927,397...75,949,585
Ensembl chr 5:75,927,405...75,949,583

G

bone marrow stromal cell antigen 2

increases expression

Oxazolone results in increased expression of BST2 mRNA

NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979

G

BTG anti-proliferation factor 1

increases expression

Oxazolone results in increased expression of BTG1 mRNA

NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649

G

BUB1 mitotic checkpoint serine/threonine kinase

decreases expression
increases expression

Oxazolone results in decreased expression of BUB1 mRNA
Oxazolone results in increased expression of BUB1 mRNA

PMID:17374397 PMID:21404309

NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650

G

BUB1 mitotic checkpoint serine/threonine kinase B

increases expression

Oxazolone results in increased expression of BUB1B mRNA

NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547

G

calcium voltage-gated channel auxiliary subunit beta 3

decreases expression

Oxazolone results in decreased expression of CACNB3 mRNA

NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074

G

carbonic anhydrase 2

decreases expression

Oxazolone results in decreased expression of CA2 mRNA

NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818

G

caspase 3

increases activity

Oxazolone results in increased activity of CASP3 protein

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

C-C motif chemokine ligand 12

increases expression

Oxazolone results in increased expression of CCL12 mRNA

NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780

G

C-C motif chemokine ligand 2

decreases expression
increases expression

Oxazolone results in decreased expression of CCL2 mRNA
Oxazolone results in increased expression of CCL2 mRNA

PMID:15585374 PMID:17374397 PMID:19647056 PMID:21404309

NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226

G

C-C motif chemokine ligand 3

increases expression

Oxazolone results in increased expression of CCL3 mRNA

PMID:15585374 PMID:19647056

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 4

increases expression

Oxazolone results in increased expression of CCL4 mRNA

PMID:15585374 PMID:19647056 PMID:21404309

NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231

G

C-C motif chemokine ligand 5

decreases expression

Oxazolone results in decreased expression of CCL5 mRNA

NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377

G

C-C motif chemokine ligand 7

increases expression

Oxazolone results in increased expression of CCL7 mRNA

PMID:19647056 PMID:21404309 PMID:21893156

NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303

G

C-C motif chemokine ligand 9

increases expression

Oxazolone results in increased expression of CCL6 mRNA

PMID:19647056 PMID:21404309

NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369

G

cellular communication network factor 1

increases expression

Oxazolone results in increased expression of CCN1 mRNA

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cyclin A2

increases expression

Oxazolone results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B2

increases expression

Oxazolone results in increased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin E1

increases expression

Oxazolone results in increased expression of CCNE1 mRNA

NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101

G

cyclin F

increases expression

Oxazolone results in increased expression of CCNF mRNA

NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101

G

C-C motif chemokine receptor 1

increases expression

Oxazolone results in increased expression of CCR1 mRNA

NCBI chr 8:123,556,286...123,561,841

G

C-C motif chemokine receptor 2

decreases expression
increases expression

Oxazolone results in decreased expression of CCR2 mRNA
Oxazolone results in increased expression of CCR2 mRNA

PMID:17374397 PMID:19647056

NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100

G

C-C motif chemokine receptor 6

decreases expression

Oxazolone results in decreased expression of CCR6 mRNA

NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603

G

C-C motif chemokine receptor 7

increases expression

Oxazolone results in increased expression of CCR7 mRNA

NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309

G

CD24 molecule

decreases expression

Oxazolone results in decreased expression of CD24A mRNA

NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662

G

CD33 molecule

decreases expression

Oxazolone results in decreased expression of CD33 mRNA

NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149

G

CD34 molecule

decreases expression

Oxazolone results in decreased expression of CD34 mRNA

NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832

G

CD36 molecule

decreases expression

Oxazolone results in decreased expression of CD36 mRNA

PMID:17374397 PMID:21404309

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD40 molecule

increases expression

Oxazolone results in increased expression of CD40 mRNA

NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534

G

CD55 molecule (Cromer blood group)

decreases expression

Oxazolone results in decreased expression of CD55 mRNA

NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831

G

CD86 molecule

increases expression

Oxazolone results in increased expression of CD86 mRNA; Oxazolone results in increased expression of CD86 protein

PMID:17374397 PMID:24136171

NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818

G

cell division cycle 20

increases expression

Oxazolone results in increased expression of CDC20 mRNA

NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512

G

cell division cycle 25A

increases expression

Oxazolone results in increased expression of CDC25A mRNA

NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701

G

cell division cycle 25B

increases expression

Oxazolone results in increased expression of CDC25B mRNA

NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272

G

cell division cycle 25C

increases expression

Oxazolone results in increased expression of CDC25C mRNA

NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185

G

cell division cycle 45

increases expression

Oxazolone results in increased expression of CDC45 mRNA

NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619

G

cell division cycle 6

increases expression

Oxazolone results in increased expression of CDC6 mRNA

NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011

G

cell division cycle 7

increases expression

Oxazolone results in increased expression of CDC7 mRNA

NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778

G

cell division cycle associated 2

increases expression

Oxazolone results in increased expression of CDCA2 mRNA

NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611

G

cadherin 8

decreases expression

Oxazolone results in decreased expression of CDH8 mRNA

NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669

G

cyclin-dependent kinase 1

increases expression

Oxazolone results in increased expression of CDK1 mRNA

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

cyclin dependent kinase 2

increases expression

Oxazolone results in increased expression of CDK2 mRNA

NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403

G

cyclin-dependent kinase-like 4

increases expression

Oxazolone results in increased expression of CDKL4 mRNA

NCBI chr 6:14,449,822...14,492,568
Ensembl chr 6:14,450,681...14,492,046

G

cyclin-dependent kinase inhibitor 1C

decreases expression

Oxazolone results in decreased expression of CDKN1C mRNA

NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048

G

CERK like autophagy regulator

decreases expression

Oxazolone results in decreased expression of CERKL mRNA

NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675

G

cell death-inducing DFFA-like effector c

increases expression

Oxazolone results in increased expression of CIDEC mRNA

NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173

G

CDGSH iron sulfur domain 1

decreases expression

Oxazolone results in decreased expression of CISD1 mRNA

NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924

G

claudin 1

multiple interactions

[Dust co-treated with Oxazolone] results in decreased expression of CLDN1 protein

NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724

G

cytidine/uridine monophosphate kinase 2

decreases expression

Oxazolone results in decreased expression of CMPK2 mRNA

NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183

G

ciliary neurotrophic factor

increases expression

Oxazolone results in increased expression of CNTF mRNA

NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877

G

COMM domain containing 3

increases expression

Oxazolone results in increased expression of COMMD3 mRNA

NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177

G

copine 3

decreases expression

Oxazolone results in decreased expression of CPNE3 mRNA

NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934

G

cAMP responsive element modulator

increases expression

Oxazolone results in increased expression of CREM mRNA

NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989

G

colony stimulating factor 2

increases expression

Oxazolone results in increased expression of CSF2 mRNA

NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199

G

colony stimulating factor 2 receptor subunit beta

increases expression

Oxazolone results in increased expression of CSF2RB mRNA; Oxazolone results in increased expression of CSF2RB2 mRNA

NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157

G

colony stimulating factor 3 receptor

increases expression

Oxazolone results in increased expression of CSF3R mRNA

NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881

G

cathepsin C

decreases expression

Oxazolone results in decreased expression of CTSC mRNA

NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387

G

C-X3-C motif chemokine ligand 1

decreases expression

Oxazolone results in decreased expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X-C motif chemokine ligand 10

increases expression
decreases expression

Oxazolone results in increased expression of CXCL10 mRNA
Oxazolone results in decreased expression of CXCL10 mRNA

PMID:19647056 PMID:21404309 PMID:21893156 PMID:23445166

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 11

increases expression

Oxazolone results in increased expression of CXCL11 mRNA

NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271

G

C-X-C motif chemokine ligand 12

decreases expression

Oxazolone results in decreased expression of CXCL12 mRNA

NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168

G

C-X-C motif chemokine ligand 14

increases expression

Oxazolone results in increased expression of CXCL14 mRNA

NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839

G

C-X-C motif chemokine ligand 16

decreases expression

Oxazolone results in decreased expression of CXCL16 mRNA

NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592

G

C-X-C motif chemokine ligand 2

increases expression
multiple interactions

Oxazolone results in increased expression of CXCL2 mRNA
[Dust co-treated with Oxazolone] results in increased expression of CXCL2 mRNA

PMID:19647056 PMID:24205293 PMID:28826779 PMID:33911793

NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075

G

C-X-C motif chemokine ligand 3

increases expression
multiple interactions

Oxazolone results in increased expression of CXCL1 mRNA
Dust promotes the reaction [Oxazolone results in increased expression of CXCL1 mRNA]

PMID:19647056 PMID:21404309 PMID:24205293 PMID:28826779 PMID:33911793

NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511

G

C-X-C motif chemokine ligand 6

multiple interactions
increases expression

Dust promotes the reaction [Oxazolone results in increased expression of CXCL5 mRNA]

PMID:19647056 PMID:33911793

NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093

G

C-X-C motif chemokine ligand 9

decreases expression
increases expression

Oxazolone results in decreased expression of CXCL9 mRNA
Oxazolone results in increased expression of CXCL9 mRNA

PMID:11379042 PMID:19647056 PMID:21404309 PMID:21893156 PMID:28826779

NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435

G

C-X-C motif chemokine receptor 3

increases expression

Oxazolone results in increased expression of CXCR3 mRNA

NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969

G

C-X-C motif chemokine receptor 4

decreases expression
increases expression

Oxazolone results in decreased expression of CXCR4 mRNA
Oxazolone results in increased expression of CXCR4 mRNA

PMID:11379042 PMID:17374397

NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883

G

cytochrome P450, family 2, subfamily f, polypeptide 4

decreases expression

Oxazolone results in decreased expression of CYP2F2 mRNA

NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896

G

cytohesin 1 interacting protein

increases expression

Oxazolone results in increased expression of CYTIP mRNA

NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993

G

dishevelled-binding antagonist of beta-catenin 1

decreases expression

Oxazolone results in decreased expression of DACT1 mRNA

NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906

G

DBF4-CDC7 kinase regulatory subunit

increases expression

Oxazolone results in increased expression of DBF4 mRNA

NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066

G

deoxycytidine kinase

increases expression

Oxazolone results in increased expression of DCK mRNA

NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247

G

dCTP pyrophosphatase 1

decreases expression

Oxazolone results in decreased expression of DCTPP1 mRNA

NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839

G

dehydrogenase/reductase 2

increases expression

Oxazolone results in increased expression of DHRS2 mRNA

NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644

G

dyskerin pseudouridine synthase 1

decreases expression

Oxazolone results in decreased expression of DKC1 mRNA

G

DLG associated protein 5

decreases expression

Oxazolone results in decreased expression of DLGAP5 mRNA

NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518

G

DnaJ heat shock protein family (Hsp40) member B4

increases expression

Oxazolone results in increased expression of DNAJB4 mRNA

NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089

G

DnaJ heat shock protein family (Hsp40) member B6

increases expression

Oxazolone results in increased expression of DNAJB6 mRNA

PMID:11379042 PMID:17374397

NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659

G

DNA nucleotidylexotransferase

decreases expression

Oxazolone results in decreased expression of DNTT mRNA

NCBI chr 1:239,856,391...239,888,283
Ensembl chr 1:239,856,391...239,888,282

G

dihydropyrimidine dehydrogenase

decreases expression

Oxazolone results in decreased expression of DPYD mRNA

PMID:17374397 PMID:21404309

NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982

G

dermatan sulfate epimerase

decreases expression

Oxazolone results in decreased expression of DSE mRNA

NCBI chr20:26,118,194...26,196,889
Ensembl chr20:26,118,196...26,196,992

G

deoxythymidylate kinase

increases expression

Oxazolone results in increased expression of DTYMK mRNA

NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870

G

dual specificity phosphatase 4

increases expression

Oxazolone results in increased expression of DUSP4 mRNA

NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138

G

deoxyuridine triphosphatase

increases expression

Oxazolone results in increased expression of DUT mRNA

PMID:18242016 PMID:21404309

NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771

G

E2F transcription factor 2

increases expression

Oxazolone results in increased expression of E2F2 mRNA

NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217

G

early growth response 2

decreases expression

Oxazolone results in decreased expression of EGR2 mRNA

NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

increases expression

Oxazolone results in increased expression of EHHADH mRNA

NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188

G

embigin

decreases expression

Oxazolone results in decreased expression of EMB mRNA

NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050

G

enolase 3

increases expression

Oxazolone results in increased expression of ENO3 mRNA

NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921

G

erythropoietin receptor

decreases expression

Oxazolone results in decreased expression of EPOR mRNA

NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257

G

ERCC excision repair 6 like, spindle assembly checkpoint helicase

increases expression

Oxazolone results in increased expression of ERCC6L mRNA

NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756

G

coagulation factor XIII A1 chain

decreases expression

Oxazolone results in decreased expression of F13A1 mRNA

NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700

G

F2R like trypsin receptor 1

increases expression

Oxazolone results in increased expression of F2RL1 mRNA

NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226

G

fatty acid binding protein 1

decreases expression

Oxazolone results in decreased expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

f-box protein 9

decreases expression

Oxazolone results in decreased expression of FBXO9 mRNA

NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949

G

Fc epsilon receptor II

decreases expression

Oxazolone results in decreased expression of FCER2A mRNA

NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476

G

Fc gamma receptor 1A

increases expression

Oxazolone results in increased expression of FCGR1 mRNA

NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994

G

Fc gamma receptor 2B

increases expression

Oxazolone results in increased expression of FCGR2B mRNA

NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778

G

FERRY endosomal RAB5 effector complex subunit 3

decreases expression

Oxazolone results in decreased expression of FERRY3 mRNA

NCBI chr 4:159,772,693...159,809,322
Ensembl chr 4:159,772,786...159,806,382

G

free fatty acid receptor 2

increases expression

Oxazolone results in increased expression of FFAR2 mRNA

NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033

G

fibrinogen-like 2

decreases expression

Oxazolone results in decreased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

flavin containing dimethylaniline monoxygenase 2

decreases expression

Oxazolone results in decreased expression of FMO2 mRNA

NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308

G

FosB proto-oncogene, AP-1 transcription factor subunit

increases expression

Oxazolone results in increased expression of FOSB mRNA

NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465

G

growth arrest and DNA-damage-inducible, beta

increases expression

Oxazolone results in increased expression of GADD45B mRNA

NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046

G

guanylate binding protein 2

increases expression

Oxazolone results in increased expression of GBP2 mRNA

NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571

G

glutamate cysteine ligase, modifier subunit

increases expression

Oxazolone results in increased expression of GCLM mRNA

NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535

G

gamma-glutamyltransferase 1

increases expression

Oxazolone results in increased expression of GGT1 mRNA

NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442

G

gamma-glutamyltransferase 5

decreases expression

Oxazolone results in decreased expression of GGT5 mRNA

NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450

G

GRB2-related adaptor protein 2

increases expression

Oxazolone results in increased expression of GRAP2 mRNA

NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877

G

glutathione S-transferase mu 1

decreases expression

Oxazolone results in decreased expression of GSTM1 mRNA

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

glutathione S-transferase, mu 5

decreases expression

Oxazolone results in decreased expression of GSTM3 mRNA

NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553

G

general transcription factor IIB

increases expression

Oxazolone results in increased expression of GTF2B mRNA

NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651

G

GULP PTB domain containing engulfment adaptor 1

decreases expression

Oxazolone results in decreased expression of GULP1 mRNA

NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005

G

granzyme A

increases expression

Oxazolone results in increased expression of GZMA mRNA

NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493

G

granzyme B

decreases expression
increases expression

Oxazolone results in decreased expression of GZMB mRNA
Oxazolone results in increased expression of GZMB mRNA

PMID:11379042 PMID:18652873 PMID:21893156

NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814

G

granzyme M

increases expression

Oxazolone results in increased expression of GZMM mRNA

NCBI chr 7:10,011,065...10,016,841
Ensembl chr 7:10,011,066...10,016,665

G

hexosaminidase subunit beta

multiple interactions
increases secretion

cupressuflavone inhibits the reaction [Oxazolone results in increased secretion of HEXB protein]

NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223

G

heme oxygenase 1

increases expression

Oxazolone results in increased expression of HMOX1 mRNA

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

heterogeneous nuclear ribonucleoprotein A3

decreases expression

Oxazolone results in decreased expression of HNRNPA3 mRNA

NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306

G

heterogeneous nuclear ribonucleoprotein H3

increases expression

Oxazolone results in increased expression of HNRNPH3 mRNA

NCBI chr20:25,616,400...25,625,814
Ensembl chr20:25,614,733...25,625,750

G

heterogeneous nuclear ribonucleoprotein L-like

increases expression

Oxazolone results in increased expression of HNRNPLL mRNA

PMID:21404309 PMID:23999411

NCBI chr 6:14,969,953...15,000,574
Ensembl chr 6:14,970,057...14,999,745

G

heat shock protein family A (Hsp70) member 4

increases expression

Oxazolone results in increased expression of HSPA4 mRNA

NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001

G

heat shock protein family A (Hsp70) member 6 like, pseudogene 1

increases expression

Oxazolone results in increased expression of HSPA6 mRNA

NCBI chr13:83,273,176...83,274,317

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

Oxazolone results in decreased expression of IDI1 mRNA

NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357

G

immediate early response 3

increases expression

Oxazolone results in increased expression of IER3 mRNA

NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583

G

interferon, alpha-inducible protein 27

increases expression

Oxazolone results in increased expression of IFI27 mRNA

NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294

G

interferon-induced protein 44-like

increases expression

Oxazolone results in increased expression of IFI44L mRNA

NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359

G

interferon-induced protein with tetratricopeptide repeats 2

decreases expression

Oxazolone results in decreased expression of IFIT2 mRNA

NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635

G

interferon-induced protein with tetratricopeptide repeats 3

increases expression

Oxazolone results in increased expression of IFIT3 mRNA

NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307

G

interferon gamma

increases expression
multiple interactions

Oxazolone results in increased expression of IFNG mRNA; Oxazolone results in increased expression of IFNG protein
12-acetoxyhawtriwaic acid lactone inhibits the reaction [Oxazolone results in increased expression of IFNG protein]; centipedic acid inhibits the reaction [Oxazolone results in increased expression of IFNG protein]; Dexamethasone inhibits the reaction [Oxazolone results in increased expression of IFNG protein]

PMID:18242016 PMID:18652873 PMID:18670081 PMID:19422874 PMID:21404309 More...

NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375

G

interferon gamma receptor 2

decreases expression

Oxazolone results in decreased expression of IFNGR2 mRNA

NCBI chr11:30,779,733...30,798,005
Ensembl chr11:30,779,733...30,798,005

G

interferon-related developmental regulator 1

increases expression

Oxazolone results in increased expression of IFRD1 mRNA

NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990

G

insulin-like growth factor binding protein 6

increases expression

Oxazolone results in increased expression of IGFBP6 mRNA

NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966

G

interleukin 10

increases expression

Oxazolone results in increased expression of IL10 protein

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

interleukin 10 receptor subunit alpha

increases expression

Oxazolone results in increased expression of IL10RA mRNA

NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061

G

interleukin 11

increases expression

Oxazolone results in increased expression of IL11 mRNA

NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129

G

interleukin 11 receptor subunit alpha 1

decreases expression

Oxazolone results in decreased expression of IL11RA1 mRNA

NCBI chr 5:56,931,824...56,941,408
Ensembl chr 5:56,935,516...56,941,408

G

interleukin 12B

increases expression

Oxazolone results in increased expression of IL12B mRNA; Oxazolone results in increased expression of IL12B protein

PMID:11379042 PMID:11708898 PMID:18652873

NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903

G

interleukin 12 receptor subunit beta 1

increases expression

Oxazolone results in increased expression of IL12RB1 mRNA

PMID:18242016 PMID:21404309

NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769

G

interleukin 15

increases expression

Oxazolone results in increased expression of IL15 mRNA

NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820

G

interleukin 18

increases expression

Oxazolone results in increased expression of IL18 protein

NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887

G

interleukin 19

increases expression

Oxazolone results in increased expression of IL19 mRNA

NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473

G

interleukin 1 alpha

multiple interactions
increases expression
affects secretion

Clofibrate inhibits the reaction [Oxazolone results in increased expression of IL1A protein]
Oxazolone affects the secretion of IL1A protein
Oxazolone results in increased expression of IL1A mRNA

PMID:11851881 PMID:12781210 PMID:18652873 PMID:33715048

NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822

G

interleukin 1 beta

decreases expression
increases expression
multiple interactions
increases secretion

Oxazolone results in decreased expression of IL1B mRNA
Oxazolone results in increased expression of IL1B mRNA; Oxazolone results in increased expression of IL1B protein
ginsenoside Re metabolite inhibits the reaction [Oxazolone results in increased expression of IL1B mRNA]; ginsenoside Rh1 inhibits the reaction [Oxazolone results in increased expression of IL1B mRNA]; SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of IL1B protein]
Oxazolone results in increased secretion of IL1B protein

PMID:11379042 PMID:16557482 PMID:18652873 PMID:18710581 PMID:19622729 More...

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 2

increases expression

Oxazolone results in increased expression of IL2 mRNA; Oxazolone results in increased expression of IL2 protein

PMID:11379042 PMID:18652873

NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566

G

interleukin 24

increases expression

Oxazolone results in increased expression of IL24 mRNA

NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487

G

interleukin 2 receptor subunit alpha

increases expression

Oxazolone results in increased expression of IL2RA mRNA

NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697

G

interleukin 2 receptor subunit beta

increases expression

Oxazolone results in increased expression of IL2RB mRNA

NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054

G

interleukin 3

decreases expression
increases expression

Oxazolone results in decreased expression of IL3 mRNA
Oxazolone results in increased expression of IL3 mRNA

PMID:11379042 PMID:18652873

NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066

G

interleukin 4

increases expression
increases secretion
multiple interactions

Oxazolone results in increased expression of IL4 mRNA; Oxazolone results in increased expression of IL4 protein
Oxazolone results in increased secretion of IL4 protein
cupressuflavone inhibits the reaction [Oxazolone results in increased secretion of IL4 protein]

PMID:11708898 PMID:18652873 PMID:19422874 PMID:28826779 PMID:29258854

NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750

G

interleukin 4 receptor

increases expression

Oxazolone results in increased expression of IL4RA mRNA

NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980

G

interleukin 6

increases secretion
increases expression

Oxazolone results in increased secretion of IL6 protein
Oxazolone results in increased expression of IL6 mRNA; Oxazolone results in increased expression of IL6 protein

PMID:17763283 PMID:18652873 PMID:19647056 PMID:24205293

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

interleukin 7

decreases expression
increases expression

Oxazolone results in decreased expression of IL7 mRNA
Oxazolone results in increased expression of IL7 mRNA

PMID:11379042 PMID:18242016 PMID:21404309

NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075

G

interleukin 7 receptor

decreases expression

Oxazolone results in decreased expression of IL7R mRNA

NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757

G

inhibin subunit beta A

increases expression

Oxazolone results in increased expression of INHBA mRNA

NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982

G

interferon regulatory factor 1

increases expression

Oxazolone results in increased expression of IRF1 mRNA

NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166

G

interferon regulatory factor 2 binding protein 2

increases expression

Oxazolone results in increased expression of IRF2BP2 mRNA

NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642

G

interferon regulatory factor 7

increases expression

Oxazolone results in increased expression of IRF7 mRNA

NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832

G

immunity-related GTPase M

increases expression

Oxazolone results in increased expression of IRGM mRNA

NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578

G

ISG15 ubiquitin-like modifier

decreases expression
increases expression

Oxazolone results in decreased expression of ISG15 mRNA
Oxazolone results in increased expression of ISG15 mRNA

PMID:11379042 PMID:21893156

NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435

G

potassium inwardly-rectifying channel, subfamily J, member 2

decreases expression

Oxazolone results in decreased expression of KCNJ2 mRNA

NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445

G

kinesin family member 23

decreases expression

Oxazolone results in decreased expression of KIF23 mRNA

NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072

G

KIT ligand

decreases expression

Oxazolone results in decreased expression of KITL mRNA

NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214

G

KLF transcription factor 10

increases expression

Oxazolone results in increased expression of KLF10 mRNA

NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994

G

KLF transcription factor 6

increases expression

Oxazolone results in increased expression of KLF6 mRNA

PMID:17374397 PMID:23999411

NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570

G

DNA ligase 1

increases expression

Oxazolone results in increased expression of LIG1 mRNA

NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413

G

loricrin cornified envelope precursor protein

multiple interactions

[Dust co-treated with Oxazolone] results in decreased expression of LORICRIN protein

NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807

G

lymphotoxin beta

increases expression

Oxazolone results in increased expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381

G

MAF bZIP transcription factor F

increases expression

Oxazolone results in increased expression of MAFF mRNA

NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851

G

MAF bZIP transcription factor K

increases expression

Oxazolone results in increased expression of MAFK mRNA

NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048
Ensembl chr12:14,833,984...14,837,048

G

minichromosome maintenance complex component 2

increases expression

Oxazolone results in increased expression of MCM2 mRNA

NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847

G

minichromosome maintenance complex component 3

increases expression

Oxazolone results in increased expression of MCM3 mRNA

NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314

G

minichromosome maintenance complex component 4

increases expression

Oxazolone results in increased expression of MCM4 mRNA

NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144

G

minichromosome maintenance complex component 5

increases expression

Oxazolone results in increased expression of MCM5 mRNA

NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389

G

minichromosome maintenance complex component 6

increases expression

Oxazolone results in increased expression of MCM6 mRNA

NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960

G

minichromosome maintenance complex component 7

increases expression

Oxazolone results in increased expression of MCM7 mRNA

NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063

G

MCTS1, re-initiation and release factor

decreases expression

Oxazolone results in decreased expression of MCTS1 mRNA

NCBI chr X:117,350,723...117,362,504
Ensembl chr X:117,350,889...117,362,504

G

microsomal glutathione S-transferase 2

decreases expression

Oxazolone results in decreased expression of MGST2 mRNA

NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828

G

matrix metallopeptidase 13

multiple interactions
increases expression

[Dust co-treated with Oxazolone] results in increased expression of MMP13 mRNA
Oxazolone results in increased expression of MMP13 mRNA

NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239

G

myeloperoxidase

decreases expression
multiple interactions
increases activity
increases expression

Oxazolone results in decreased expression of MPO mRNA
resveratrol inhibits the reaction [Oxazolone results in increased activity of MPO protein]
tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of MPO protein]

PMID:17374397 PMID:22200888 PMID:24055189

NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819

G

mitochondrial ribosomal protein L35

decreases expression

Oxazolone results in decreased expression of MRPL35 mRNA

NCBI chr 4:103,865,812...103,876,687
Ensembl chr 4:103,865,812...103,880,887

G

mitochondrial ribosomal protein S6

decreases expression

Oxazolone results in decreased expression of MRPS6 mRNA

NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484

G

major urinary protein 4

increases expression

Oxazolone results in increased expression of MUP4 mRNA

NCBI chr 5:74,961,143...74,964,686
Ensembl chr 5:74,842,319...75,061,474

G

MX dynamin like GTPase 1

increases expression

Oxazolone results in increased expression of MX2 mRNA

NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507

G

MYB proto-oncogene, transcription factor

decreases expression

Oxazolone results in decreased expression of MYB mRNA

NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057

G

MYC proto-oncogene, bHLH transcription factor

decreases expression

Oxazolone results in decreased expression of MYC mRNA

NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630

G

nicotinamide phosphoribosyltransferase

increases expression

Oxazolone results in increased expression of NAMPT mRNA

NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100

G

nuclear factor kappa B subunit 1

decreases expression

Oxazolone results in decreased expression of NFKB1 mRNA

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404

G

ninjurin 1

increases expression

Oxazolone results in increased expression of NINJ1 mRNA

NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704

G

natural killer cell granule protein 7

increases expression

Oxazolone results in increased expression of NKG7 mRNA

NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983

G

nitric oxide synthase 2

increases expression
multiple interactions

Oxazolone results in increased expression of NOS2 mRNA
tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of NOS2 mRNA]

NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210

G

nuclear receptor subfamily 3, group C, member 1

increases expression

Oxazolone results in increased expression of NR3C1 mRNA

NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375

G

neuronal regeneration related protein

decreases expression

Oxazolone results in decreased expression of NREP mRNA

NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591

G

nudix hydrolase 19

increases expression

Oxazolone results in increased expression of NUDT19 mRNA

NCBI chr 1:88,214,475...88,226,072
Ensembl chr 1:88,214,480...88,226,207

G

nucleoporin 155

increases expression

Oxazolone results in increased expression of NUP155 mRNA

NCBI chr 2:57,201,310...57,252,918
Ensembl chr 2:57,201,272...57,254,148

G

nucleoporin 88

increases expression

Oxazolone results in increased expression of NUP88 mRNA

NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257

G

2'-5'-oligoadenylate synthetase-like

increases expression

Oxazolone results in increased expression of OASL mRNA

NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641

G

ornithine decarboxylase 1

increases expression

Oxazolone results in increased expression of ODC1 mRNA

NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440

G

origin recognition complex, subunit 1

increases expression

Oxazolone results in increased expression of ORC1 mRNA

NCBI chr 5:123,324,273...123,348,375
Ensembl chr 5:123,324,315...123,348,375

G

origin recognition complex, subunit 6

increases expression

Oxazolone results in increased expression of ORC6 mRNA

NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662

G

oncostatin M

increases expression

Oxazolone results in increased expression of OSM mRNA

NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313

G

OTU deubiquitinase 1

increases expression

Oxazolone results in increased expression of OTUD1 mRNA

NCBI chr17:82,259,920...82,262,770
Ensembl chr17:82,259,840...82,262,995

G

phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase

decreases expression

Oxazolone results in decreased expression of PAICS mRNA

NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635

G

p21 (RAC1) activated kinase 2

increases expression

Oxazolone results in increased expression of PAK2 mRNA

NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816

G

poly (ADP-ribose) polymerase family, member 14

increases expression

Oxazolone results in increased expression of PARP14 mRNA

NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916

G

proliferating cell nuclear antigen

increases expression

Oxazolone results in increased expression of PCNA mRNA

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

phosphodiesterase 4D

increases expression

Oxazolone results in increased expression of PDE4D mRNA

NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884

G

paternally expressed 10

increases expression

Oxazolone results in increased expression of PEG10 mRNA

NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621

G

platelet factor 4

increases expression

Oxazolone results in increased expression of PF4 mRNA

NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365

G

PHD finger protein 11

increases expression

Oxazolone results in increased expression of PHF11 mRNA

NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009

G

pleckstrin homology-like domain, family A, member 1

increases expression

Oxazolone results in increased expression of PHLDA1 mRNA

NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861

G

protein kinase, membrane associated tyrosine/threonine 1

increases expression

Oxazolone results in increased expression of PKMYT1 mRNA

NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995

G

plasminogen activator, tissue type

increases expression

Oxazolone results in increased expression of PLAT mRNA

NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223

G

polo-like kinase 1

increases expression

Oxazolone results in increased expression of PLK1 mRNA

NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression

Oxazolone results in increased expression of PMAIP1 mRNA

NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429

G

DNA polymerase alpha 1, catalytic subunit

increases expression

Oxazolone results in increased expression of POLA1 mRNA

NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536

G

DNA polymerase alpha 2, accessory subunit

increases expression

Oxazolone results in increased expression of POLA2 mRNA

NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348

G

DNA polymerase delta 3, accessory subunit

increases expression

Oxazolone results in increased expression of POLD3 mRNA

NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665

G

DNA polymerase epsilon, catalytic subunit

increases expression

Oxazolone results in increased expression of POLE mRNA

NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939

G

DNA polymerase epsilon 2, accessory subunit

increases expression

Oxazolone results in increased expression of POLE2 mRNA

NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305

G

DNA polymerase epsilon 3, accessory subunit

increases expression

Oxazolone results in increased expression of POLE3 mRNA

NCBI chr 5:75,973,941...75,977,175
Ensembl chr 5:75,974,717...75,977,231
Ensembl chr 7:75,974,717...75,977,231

G

inorganic pyrophosphatase 1

increases expression

Oxazolone results in increased expression of PPA1 mRNA

NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215

G

peroxisome proliferator-activated receptor gamma

increases expression
multiple interactions

Oxazolone results in increased expression of PPARG protein
tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein]

NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468

G

pro-platelet basic protein

increases expression

Oxazolone results in increased expression of PPBP mRNA

NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130

G

protein phosphatase 2, regulatory subunit B'', alpha

decreases expression

Oxazolone results in decreased expression of PPP2R3A mRNA

NCBI chr 8:101,703,512...101,841,530
Ensembl chr 8:101,704,778...101,841,502

G

DNA primase subunit 1

increases expression

Oxazolone results in increased expression of PRIM1 mRNA

NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526

G

proteasome 20S subunit alpha 5

decreases expression

Oxazolone results in decreased expression of PSMA5 mRNA

NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731

G

proteasome 20S subunit beta 10

increases expression

Oxazolone results in increased expression of PSMB10 mRNA

NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626

G

proteasome 20S subunit beta 8

increases expression

Oxazolone results in increased expression of PSMB8 mRNA

NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283

G

proteasome 20S subunit beta 9

increases expression

Oxazolone results in increased expression of PSMB9 mRNA

NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512

G

proteasome activator subunit 4

increases expression

Oxazolone results in increased expression of PSME4 mRNA

NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408

G

prostaglandin E receptor 3

decreases expression

Oxazolone results in decreased expression of PTGER3 mRNA

NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434

G

prostaglandin-endoperoxide synthase 2

multiple interactions
increases expression

ginsenoside Re metabolite inhibits the reaction [Oxazolone results in increased expression of PTGS2 mRNA]; ginsenoside Rh1 inhibits the reaction [Oxazolone results in increased expression of PTGS2 mRNA]; tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PTGS2 mRNA]

PMID:16557482 PMID:22200888

NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188

G

protein tyrosine phosphatase 4A1

increases expression

Oxazolone results in increased expression of PTP4A1 mRNA

NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964

G

PTTG1 regulator of sister chromatid separation, securin

increases expression

Oxazolone results in increased expression of PTTG1 mRNA

NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837

G

RAB20, member RAS oncogene family

increases expression

Oxazolone results in increased expression of RAB20 mRNA

NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529

G

RAB32, member RAS oncogene family

decreases expression

Oxazolone results in decreased expression of RAB32 mRNA

NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934

G

RB transcriptional corepressor like 1

increases expression

Oxazolone results in increased expression of RBL1 mRNA

NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330

G

RNA binding motif protein 17

decreases expression

Oxazolone results in decreased expression of RBM17 mRNA

NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014

G

recombination signal binding protein for immunoglobulin kappa J region

decreases expression

Oxazolone results in decreased expression of RBPJ mRNA

NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353

G

regulator of chromosome condensation 1

increases expression

Oxazolone results in increased expression of RCC1 mRNA

NCBI chr 5:144,526,025...144,544,445
Ensembl chr 5:144,526,025...144,544,577

G

reticulocalbin 1

increases expression

Oxazolone results in increased expression of RCN1 mRNA

NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295

G

RecQ like helicase 4

increases expression

Oxazolone results in increased expression of RECQL4 mRNA

NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619

G

RELA proto-oncogene, NF-kB subunit

increases expression
multiple interactions

Oxazolone results in increased expression of RELA mRNA
tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of RELA mRNA]

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

replication factor C subunit 3

increases expression

Oxazolone results in increased expression of RFC3 mRNA

NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778

G

replication factor C subunit 4

increases expression

Oxazolone results in increased expression of RFC4 mRNA

NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122

G

replication factor C subunit 5

increases expression

Oxazolone results in increased expression of RFC5 mRNA

NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312

G

similar to interferon-inducible GTPase

increases expression

Oxazolone results in increased expression of RGD1309362 mRNA

G

regulator of G-protein signaling 1

increases expression

Oxazolone results in increased expression of RGS1 mRNA

NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984

G

ring finger protein, LIM domain interacting

increases expression

Oxazolone results in increased expression of RLIM mRNA

NCBI chr X:68,983,259...69,004,368
Ensembl chr X:68,988,375...69,004,271

G

ribonuclease A family member 2

decreases expression

Oxazolone results in decreased expression of RNASE2A mRNA

NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479

G

ribonuclease H2, subunit B

increases expression

Oxazolone results in increased expression of RNASEH2B mRNA

NCBI chr15:36,541,200...36,592,016
Ensembl chr15:36,541,218...36,584,118

G

ribosomal protein L27A

increases expression

Oxazolone results in increased expression of RPL27A mRNA

NCBI chr 1:163,539,732...163,542,771

G

ribonucleotide reductase catalytic subunit M1

increases expression

Oxazolone results in increased expression of RRM1 mRNA

NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261

G

ribonucleotide reductase regulatory subunit M2

increases expression

Oxazolone results in increased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773

G

receptor (chemosensory) transporter protein 4

increases expression

Oxazolone results in increased expression of RTP4 mRNA

PMID:18242016 PMID:19647056 PMID:21893156

NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437

G

RUNX family transcription factor 3

increases expression

Oxazolone results in increased expression of RUNX3 mRNA

NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156

G

RING1 and YY1 binding protein

increases expression

Oxazolone results in increased expression of RYBP mRNA

NCBI chr 4:132,876,260...132,928,328
Ensembl chr 4:132,876,361...132,928,316

G

S100 calcium binding protein B

decreases expression

Oxazolone results in decreased expression of S100B mRNA

NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743

G

spermidine/spermine N1-acetyl transferase 1

increases expression

Oxazolone results in increased expression of SAT1 mRNA

NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813

G

selectin P

increases expression

Oxazolone results in increased expression of SELP mRNA

NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845

G

septin 11

decreases expression

Oxazolone results in decreased expression of SEPTIN11 mRNA

NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853

G

Serpine1 mRNA binding protein 1

decreases expression

Oxazolone results in decreased expression of SERBP1 mRNA

NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813

G

S-phase kinase associated protein 2

increases expression

Oxazolone results in increased expression of SKP2 mRNA

NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338

G

SLAM family member 8

decreases expression

Oxazolone results in decreased expression of SLAMF8 mRNA

NCBI chr13:85,047,729...85,057,571
Ensembl chr13:85,047,727...85,057,211

G

solute carrier family 2 member 3

increases expression

Oxazolone results in increased expression of SLC2A3 mRNA

NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472

G

solute carrier family 7 member 3

increases expression

Oxazolone results in increased expression of SLC7A3 mRNA

NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708

G

solute carrier family 7 member 5

increases expression

Oxazolone results in increased expression of SLC7A5 mRNA

NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823

G

structural maintenance of chromosomes 1A

decreases expression

Oxazolone results in decreased expression of SMC1A mRNA

NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056

G

sorting nexin 9

increases expression

Oxazolone results in increased expression of SNX9 mRNA

NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036

G

superoxide dismutase 3

decreases expression

Oxazolone results in decreased expression of SOD3 mRNA

NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990

G

sphingosine kinase 1

increases activity
multiple interactions

Oxazolone results in increased activity of SPHK1 protein
resveratrol inhibits the reaction [Oxazolone results in increased activity of SPHK1 protein]

NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240

G

squalene epoxidase

increases expression

Oxazolone results in increased expression of SQLE mRNA

NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618

G

signal recognition particle 72

decreases expression

Oxazolone results in decreased expression of SRP72 mRNA

NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729

G

serine and arginine rich splicing factor 7

increases expression

Oxazolone results in increased expression of SRSF7 mRNA

NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965

G

somatostatin receptor 4

decreases response to substance
multiple interactions

SSTR4 results in decreased susceptibility to Oxazolone
SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of IL1B protein]; SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of TNF protein]

NCBI chr 3:135,854,826...135,856,689
Ensembl chr 3:135,854,826...135,856,689

G

signal transducer and activator of transcription 1

decreases expression
increases expression

Oxazolone results in decreased expression of STAT1 mRNA
Oxazolone results in increased expression of STAT1 mRNA

PMID:17374397 PMID:21893156

NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540

G

signal transducer and activator of transcription 2

increases expression

Oxazolone results in increased expression of STAT2 mRNA

NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967

G

syntaxin 11

increases expression

Oxazolone results in increased expression of STX11 mRNA

NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164

G

TATA-box binding protein associated factor 4b

increases expression

Oxazolone results in increased expression of TAF4B mRNA

NCBI chr18:5,952,737...6,086,408
Ensembl chr18:5,952,769...6,068,307

G

transporter 1, ATP binding cassette subfamily B member

increases expression

Oxazolone results in increased expression of TAP1 mRNA

NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901

G

transporter 2, ATP binding cassette subfamily B member

increases expression

Oxazolone results in increased expression of TAP2 mRNA

NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407

G

transcription factor Dp-1

increases expression

Oxazolone results in increased expression of TFDP1 mRNA

PMID:18242016 PMID:21404309

NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817

G

transcription factor EC

increases expression

Oxazolone results in increased expression of TFEC mRNA

NCBI chr 4:45,106,129...45,180,236
Ensembl chr 4:45,107,641...45,180,236

G

transforming growth factor, beta receptor 2

decreases expression

Oxazolone results in decreased expression of TGFBR2 mRNA

NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228

G

TGFB-induced factor homeobox 1

increases expression

Oxazolone results in increased expression of TGIF1 mRNA

NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802

G

TIR domain containing adaptor molecule 2

increases expression

Oxazolone results in increased expression of TICAM2 mRNA

NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462

G

tigger transposable element derived 2

increases expression

Oxazolone results in increased expression of TIGD2 mRNA

NCBI chr 4:88,414,366...88,417,458
Ensembl chr 4:88,414,518...88,417,785

G

tight junction protein 1

multiple interactions

[Dust co-treated with Oxazolone] results in decreased expression of TJP1 protein

NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432

G

thymidine kinase 1

increases expression

Oxazolone results in increased expression of TK1 mRNA

NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920

G

thymidine kinase 2

decreases expression

Oxazolone results in decreased expression of TK2 mRNA

NCBI chr19:708,859...731,786
Ensembl chr19:708,891...730,924

G

tumor necrosis factor

multiple interactions
increases expression

Clofibrate inhibits the reaction [Oxazolone results in increased expression of TNF protein]; ginsenoside Re metabolite inhibits the reaction [Oxazolone results in increased expression of TNF mRNA]; ginsenoside Rh1 inhibits the reaction [Oxazolone results in increased expression of TNF mRNA]; SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of TNF protein]; tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of TNF mRNA]
Oxazolone results in increased expression of TNF mRNA; Oxazolone results in increased expression of TNF protein

PMID:11851881 PMID:16557482 PMID:19622729 PMID:19647056 PMID:22200888 More...

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

TNF receptor superfamily member 10b

increases expression

Oxazolone results in increased expression of TNFRSF10A mRNA

NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467

G

TNF receptor superfamily member 19

increases expression

Oxazolone results in increased expression of TNFRSF19 mRNA

NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795

G

TNF receptor superfamily member 4

increases expression

Oxazolone results in increased expression of TNFRSF4 mRNA

NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599

G

TNF superfamily member 13

decreases expression

Oxazolone results in decreased expression of TNFSF13 mRNA

NCBI chr10:54,400,054...54,403,723
Ensembl chr10:54,400,065...54,403,042

G

TNF superfamily member 14

increases expression

Oxazolone results in increased expression of TNFSF14 mRNA

NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216

G

three prime repair exonuclease 1

increases expression

Oxazolone results in increased expression of TREX1 mRNA

NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796

G

tribbles pseudokinase 1

increases expression

Oxazolone results in increased expression of TRIB1 mRNA

NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731

G

tripartite motif-containing 27

increases expression

Oxazolone results in increased expression of TRIM27 mRNA

NCBI chr17:43,538,282...43,550,633
Ensembl chr17:43,538,285...43,550,643

G

thioredoxin 1

increases expression

Oxazolone results in increased expression of TXN1 mRNA

NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629

G

thioredoxin reductase 1

increases expression

Oxazolone results in increased expression of TXNRD1 mRNA

NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863

G

thymidylate synthetase

increases expression

Oxazolone results in increased expression of TYMS mRNA

NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536

G

ubiquitin D

increases expression

Oxazolone results in increased expression of UBD mRNA

NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639
Ensembl chr20:1,385,864...1,408,639

G

uridine-cytidine kinase 2

increases expression

Oxazolone results in increased expression of UCK2 mRNA

NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352

G

beta-ureidopropionase 1

decreases expression

Oxazolone results in decreased expression of UPB1 mRNA

NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590

G

uridine phosphorylase 1

increases expression

Oxazolone results in increased expression of UPP1 mRNA

NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462

G

ubiquitin specific peptidase 18

increases expression

Oxazolone results in increased expression of USP18 mRNA

NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144

G

vascular endothelial growth factor A

increases expression

Oxazolone results in increased expression of VEGFA mRNA

NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641

G

Z-DNA binding protein 1

increases expression

Oxazolone results in increased expression of ZBP1 mRNA

PMID:18242016 PMID:19647056

NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870

G

zinc finger protein 36, C3H type-like 1

decreases expression

Oxazolone results in decreased expression of ZFP36L1 mRNA

NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748

G

zinc finger protein 870

increases expression

Oxazolone results in increased expression of ZNF670 mRNA

NCBI chr 7:11,990,146...12,003,813
Ensembl chr 7:11,990,148...12,003,813

G

zinc finger FYVE-type containing 26

decreases expression

Oxazolone results in decreased expression of ZFYVE26 mRNA

NCBI chr 6:98,031,874...98,095,538
Ensembl chr 6:98,032,520...98,095,480

G

zinc finger MYM-type containing 3

decreases expression

Oxazolone results in decreased expression of ZMYM3 mRNA

NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782

G

zinc finger, X-linked, duplicated B

increases expression

Oxazolone results in increased expression of ZXDB mRNA

NCBI chr  X:59,700,765...59,706,737
Ensembl chr  X:59,701,178...59,703,871
Ensembl chr  X:59,701,178...59,703,871

Muraglitazar

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha 1,3-galactosyltransferase 2

decreases expression

muraglitazar results in decreased expression of A3GALT2 mRNA

NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641

G

ATP binding cassette subfamily C member 2

decreases expression

muraglitazar results in decreased expression of ABCC2 mRNA

NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238

G

ATP binding cassette subfamily D member 3

increases expression

muraglitazar results in increased expression of ABCD3 mRNA

NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020

G

ATP binding cassette subfamily G member 5

increases expression

muraglitazar results in increased expression of ABCG5 mRNA

NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563

G

abhydrolase domain containing 1

increases expression

muraglitazar results in increased expression of ABHD1 mRNA

NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514

G

ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase

increases expression

muraglitazar results in increased expression of ABO mRNA

NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423

G

acetyl-CoA acyltransferase 1A

increases expression

muraglitazar results in increased expression of ACAA1 mRNA

NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624

G

acetyl-CoA acyltransferase 2

increases expression

muraglitazar results in increased expression of ACAA2 mRNA

NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249

G

acyl-CoA dehydrogenase medium chain

increases expression

muraglitazar results in increased expression of ACADM mRNA

NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147

G

acyl-CoA dehydrogenase, very long chain

increases expression

muraglitazar results in increased expression of ACADVL mRNA

NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075

G

acetyl-CoA acetyltransferase 1

increases expression

muraglitazar results in increased expression of ACAT1 mRNA

NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855

G

aconitase 1

increases expression

muraglitazar results in increased expression of ACO1 mRNA

NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391

G

acyl-CoA thioesterase 1

increases expression

muraglitazar results in increased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA thioesterase 12

increases expression

muraglitazar results in increased expression of ACOT12 mRNA

NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536

G

acyl-CoA thioesterase 2

increases expression

muraglitazar results in increased expression of ACOT2 mRNA

NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245

G

acyl-CoA thioesterase 7

increases expression

muraglitazar results in increased expression of ACOT7 mRNA

NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309

G

acyl-CoA oxidase 1

increases expression
multiple interactions

muraglitazar results in increased expression of ACOX1 mRNA
[muraglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA

PMID:21515302 PMID:24534255

NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232

G

acid phosphatase 3

increases expression

muraglitazar results in increased expression of ACP3 mRNA

NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236

G

acyl-CoA synthetase long-chain family member 1

increases expression

muraglitazar results in increased expression of ACSL1 mRNA

NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541

G

acyl-CoA synthetase long-chain family member 3

increases expression

muraglitazar results in increased expression of ACSL3 mRNA

NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627

G

acyl-CoA synthetase medium-chain family member 2

increases expression

muraglitazar results in increased expression of ACSM2A mRNA

NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116

G

acyl-CoA synthetase medium-chain family member 3

increases expression

muraglitazar results in increased expression of ACSM3 mRNA

NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184

G

actinin, alpha 1

decreases expression

muraglitazar results in decreased expression of ACTN1 mRNA

NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251

G

adenylate cyclase 10

increases expression

muraglitazar results in increased expression of ADCY10 mRNA

NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951

G

adhesion G protein-coupled receptor E1

decreases expression

muraglitazar results in decreased expression of ADGRE1 mRNA

NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000

G

adhesion G protein-coupled receptor G2

increases expression

muraglitazar results in increased expression of ADGRG2 mRNA

NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609

G

alcohol dehydrogenase 6 (class V)

increases expression

muraglitazar results in increased expression of ADH6 mRNA

NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534

G

adiponectin, C1Q and collagen domain containing

decreases expression

muraglitazar results in decreased expression of ADIPOQ mRNA

NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564

G

adrenomedullin

increases expression

muraglitazar results in increased expression of ADM mRNA

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

adrenoceptor alpha 1B

increases expression

muraglitazar results in increased expression of ADRA1B mRNA

NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919

G

adenylosuccinate synthase 1

increases expression

muraglitazar results in increased expression of ADSS1 mRNA

NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998

G

androgen-dependent TFPI-regulating protein

increases expression

muraglitazar results in increased expression of ADTRP mRNA

NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826

G

alanine--glyoxylate aminotransferase

increases expression

muraglitazar results in increased expression of AGXT mRNA

NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336

G

allograft inflammatory factor 1

decreases expression

muraglitazar results in decreased expression of AIF1 mRNA

NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668

G

aldo-keto reductase family 1, member D1

increases expression

muraglitazar results in increased expression of AKR1D1 mRNA

NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372

G

albumin

multiple interactions

[Oleic Acid co-treated with muraglitazar] results in increased expression of ALB mRNA

NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836

G

activated leukocyte cell adhesion molecule

decreases expression

muraglitazar results in decreased expression of ALCAM mRNA

NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954

G

aldehyde dehydrogenase 1 family, member A1

increases expression

muraglitazar results in increased expression of ALDH1A1 mRNA

NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961

G

aldehyde dehydrogenase 3 family, member B1

decreases expression

muraglitazar results in decreased expression of ALDH3B1 mRNA

NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921

G

aldehyde dehydrogenase 6 family, member A1

increases expression

muraglitazar results in increased expression of ALDH6A1 mRNA

NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656

G

aldolase, fructose-bisphosphate B

decreases expression

muraglitazar results in decreased expression of ALDOB mRNA

NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116

G

alkaline phosphatase, intestinal

decreases expression

muraglitazar results in decreased expression of ALPI mRNA

NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877

G

alkaline phosphatase, biomineralization associated

increases expression

muraglitazar results in increased expression of ALPL mRNA

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

adenosine monophosphate deaminase 3

decreases expression

muraglitazar results in decreased expression of AMPD3 mRNA

NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887

G

angiopoietin-like 4

increases expression

muraglitazar results in increased expression of ANGPTL4 mRNA

NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519

G

ankyrin repeat domain 1

decreases expression

muraglitazar results in decreased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919

G

ANTXR cell adhesion molecule 1

increases expression

muraglitazar results in increased expression of ANTXR1 mRNA

NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232

G

aminopeptidase O

decreases expression

muraglitazar results in decreased expression of AOPEP mRNA

NCBI chr17:1,811,281...2,127,316
Ensembl chr17:1,811,980...2,127,331

G

apoptotic peptidase activating factor 1

decreases expression

muraglitazar results in decreased expression of APAF1 mRNA

NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540

G

apelin

increases expression

muraglitazar results in increased expression of APLN mRNA

NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391

G

apolipoprotein C3

multiple interactions

[Oleic Acid co-treated with muraglitazar] results in increased expression of APOC3 mRNA

NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583

G

aquaporin 3 (Gill blood group)

increases expression

muraglitazar results in increased expression of AQP3 mRNA

NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720

G

aquaporin 7

increases expression

muraglitazar results in increased expression of AQP7 mRNA

NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642

G

amphiregulin

decreases expression

muraglitazar results in decreased expression of AREG mRNA

NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535

G

arginase 2

decreases expression

muraglitazar results in decreased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

AT-rich interaction domain 5A

decreases expression

muraglitazar results in decreased expression of ARID5A mRNA

NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597

G

ankyrin repeat and SOCS box-containing 2

increases expression

muraglitazar results in increased expression of ASB2 mRNA

NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854

G

acid sensing ion channel subunit 3

decreases expression

muraglitazar results in decreased expression of ASIC3 mRNA

NCBI chr 4:10,760,509...10,764,987
Ensembl chr 4:10,760,597...10,764,643

G

aurora kinase B

decreases expression

muraglitazar results in decreased expression of AURKB mRNA

NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837

G

arginine vasopressin

increases expression

muraglitazar results in increased expression of AVP mRNA

NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425

G

arginine vasopressin receptor 1A

decreases expression

muraglitazar results in decreased expression of AVPR1A mRNA

NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215

G

axin 2

decreases expression

muraglitazar results in decreased expression of AXIN2 mRNA

NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231

G

BCL2-related protein A1

decreases expression

muraglitazar results in decreased expression of BCL2A1 mRNA

NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998

G

BCL2-interacting killer

decreases expression

muraglitazar results in decreased expression of BIK mRNA

NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296

G

basic helix-loop-helix ARNT like 2

decreases expression

muraglitazar results in decreased expression of BMAL2 mRNA

NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949

G

bone morphogenetic protein 2

decreases expression

muraglitazar results in decreased expression of BMP2 mRNA

NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397

G

biotinidase

increases expression

muraglitazar results in increased expression of BTD mRNA

NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945

G

complement C1s

decreases expression

muraglitazar results in decreased expression of C1S mRNA

NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303

G

complement component 4 binding protein, beta

decreases expression

muraglitazar results in decreased expression of C4BPB mRNA

NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817

G

complement C5a receptor 1

decreases expression

muraglitazar results in decreased expression of C5AR1 mRNA

NCBI chr 1:76,948,622...76,959,826

G

complement C5a receptor 2

decreases expression

muraglitazar results in decreased expression of C5AR2 mRNA

NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517

G

calcitonin-related polypeptide, beta

decreases expression

muraglitazar results in decreased expression of CALCB mRNA

NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125

G

calcium homeostasis modulator family member 6

decreases expression

muraglitazar results in decreased expression of CALHM6 mRNA

NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278

G

catalase

increases expression

muraglitazar results in increased expression of CAT mRNA

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

cation channel sperm associated auxiliary subunit delta

increases expression

muraglitazar results in increased expression of CATSPERD mRNA

NCBI chr 9:1,459,967...1,498,342
Ensembl chr 9:1,460,001...1,498,344

G

cystathionine beta synthase

increases expression

muraglitazar results in increased expression of CBS mRNA

NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764

G

C-C motif chemokine ligand 2

decreases expression

muraglitazar results in decreased expression of CCL2 mRNA

NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226

G

C-C motif chemokine ligand 20

decreases expression

muraglitazar results in decreased expression of CCL20 mRNA

NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629

G

C-C motif chemokine ligand 3

decreases expression

muraglitazar results in decreased expression of CCL3 mRNA

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 4

decreases expression

muraglitazar results in decreased expression of CCL4 mRNA

NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231

G

C-C motif chemokine ligand 7

decreases expression

muraglitazar results in decreased expression of CCL7 mRNA

NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303

G

C-C motif chemokine ligand 9

decreases expression

muraglitazar results in decreased expression of CCL6 mRNA

NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369

G

cellular communication network factor 2

decreases expression

muraglitazar results in decreased expression of CCN2 mRNA

NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734

G

CD36 molecule

increases expression

muraglitazar results in increased expression of CD36 mRNA

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD44 molecule

decreases expression

muraglitazar results in decreased expression of CD44 mRNA

NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620

G

CD9 molecule

decreases expression

muraglitazar results in decreased expression of CD9 mRNA

NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222

G

cell division cycle 25A

increases expression

muraglitazar results in increased expression of CDC25A mRNA

NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701

G

cadherin 1

decreases expression

muraglitazar results in decreased expression of CDH1 mRNA

NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775

G

CCAAT/enhancer binding protein beta

increases expression

muraglitazar results in increased expression of CEBPB mRNA

NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473

G

centromere protein U

decreases expression

muraglitazar results in decreased expression of CENPU mRNA

NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823

G

carboxylesterase 2H

increases expression

muraglitazar results in increased expression of CES2 mRNA

NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830

G

carboxylesterase-like 1

increases expression

muraglitazar results in increased expression of CESL1 mRNA

NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608

G

complement factor D

increases expression

muraglitazar results in increased expression of CFD mRNA

NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053

G

cholesterol 25-hydroxylase

decreases expression

muraglitazar results in decreased expression of CH25H mRNA

NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195

G

coiled-coil-helix-coiled-coil-helix domain containing 10

increases expression

muraglitazar results in increased expression of CHCHD10 mRNA

NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763

G

chromogranin B

increases expression

muraglitazar results in increased expression of CHGB mRNA

NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166

G

choline kinase beta

increases expression

muraglitazar results in increased expression of CHKB mRNA

NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461

G

cell adhesion molecule L1-like

decreases expression

muraglitazar results in decreased expression of CHL1 mRNA

NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265

G

choline phosphotransferase 1

increases expression

muraglitazar results in increased expression of CHPT1 mRNA

NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103

G

cholinergic receptor nicotinic alpha 2 subunit

increases expression

muraglitazar results in increased expression of CHRNA2 mRNA

NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601

G

cholinergic receptor nicotinic alpha 6 subunit

decreases expression

muraglitazar results in decreased expression of CHRNA6 mRNA

NCBI chr16:64,697,741...64,704,441
Ensembl chr16:64,697,741...64,704,441

G

cholinergic receptor nicotinic gamma subunit

decreases expression

muraglitazar results in decreased expression of CHRNG mRNA

NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482

G

Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1

decreases expression

muraglitazar results in decreased expression of CITED1 mRNA

NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

decreases expression

muraglitazar results in decreased expression of CITED2 mRNA

NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897

G

claudin 1

increases expression

muraglitazar results in increased expression of CLDN1 mRNA

NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724

G

caseinolytic mitochondrial matrix peptidase chaperone subunit X

increases expression

muraglitazar results in increased expression of CLPX mRNA

NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082

G

calsyntenin 2

decreases expression

muraglitazar results in decreased expression of CLSTN2 mRNA

NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731

G

calaxin

decreases expression

muraglitazar results in decreased expression of CLXN mRNA

NCBI chr11:85,977,231...85,996,561
Ensembl chr11:85,983,304...85,996,538

G

carboxymethylenebutenolidase homolog

increases expression

muraglitazar results in increased expression of CMBL mRNA

NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009

G

chemerin chemokine-like receptor 2

decreases expression

muraglitazar results in decreased expression of CMKLR2 mRNA

NCBI chr 9:64,583,310...64,617,883
Ensembl chr 9:64,585,594...64,586,655

G

calponin 1

decreases expression

muraglitazar results in decreased expression of CNN1 mRNA

NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098

G

collagen type I alpha 2 chain

decreases expression

muraglitazar results in decreased expression of COL1A2 mRNA

NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867

G

collagen like tail subunit of asymmetric acetylcholinesterase

increases expression

muraglitazar results in increased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107

G

carnitine palmitoyltransferase 1A

multiple interactions
increases expression

muraglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]
muraglitazar results in increased expression of CPT1A mRNA

PMID:21515302 PMID:24534255

NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055

G

carnitine palmitoyltransferase 1B

increases expression

muraglitazar results in increased expression of CPT1B mRNA

NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404

G

carnitine palmitoyltransferase 2

increases expression
multiple interactions

muraglitazar results in increased expression of CPT2 mRNA
[muraglitazar co-treated with Oleic Acid] results in increased expression of CPT2 mRNA

PMID:21515302 PMID:24534255

NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095

G

carnitine O-acetyltransferase

increases expression

muraglitazar results in increased expression of CRAT mRNA

NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255

G

cAMP responsive element binding protein 3-like 3

increases expression

muraglitazar results in increased expression of CREB3L3 mRNA

NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048

G

carnitine O-octanoyltransferase

increases expression

muraglitazar results in increased expression of CROT mRNA

NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109

G

cysteine sulfinic acid decarboxylase

increases expression

muraglitazar results in increased expression of CSAD mRNA

NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615

G

colony stimulating factor 1

decreases expression

muraglitazar results in decreased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

colony stimulating factor 2 receptor subunit beta

decreases expression

muraglitazar results in decreased expression of CSF2RB mRNA

NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157

G

cysteine and glycine rich protein 3

decreases expression

muraglitazar results in decreased expression of CSRP3 mRNA

NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653

G

C-terminal binding protein 2

increases expression

muraglitazar results in increased expression of CTBP2 mRNA

NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222

G

cystathionine gamma-lyase

increases expression

muraglitazar results in increased expression of CTH mRNA

NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234

G

C-X-C motif chemokine ligand 1

decreases expression

muraglitazar results in decreased expression of CXCL1 mRNA

NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215

G

C-X-C motif chemokine ligand 10

decreases expression

muraglitazar results in decreased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 11

decreases expression

muraglitazar results in decreased expression of CXCL11 mRNA

NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271

G

C-X-C motif chemokine ligand 12

increases expression

muraglitazar results in increased expression of CXCL12 mRNA

NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168

G

C-X-C motif chemokine ligand 2

decreases expression

muraglitazar results in decreased expression of CXCL2 mRNA

NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075

G

cytochrome P450, family 17, subfamily a, polypeptide 1

increases expression

muraglitazar results in increased expression of CYP17A1 mRNA

NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 26, subfamily a, polypeptide 1

increases expression

muraglitazar results in increased expression of CYP26A1 mRNA

NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204

G

cytochrome P450, family 2, subfamily b, polypeptide 2

increases expression

muraglitazar results in increased expression of CYP2B2 mRNA

NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566

G

cytochrome P450, family 2, subfamily j, polypeptide 4

increases expression

muraglitazar results in increased expression of CYP2J4 mRNA

NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

increases expression

muraglitazar results in increased expression of CYP3A23-3A1 mRNA

NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030

G

cytochrome P450, family 3, subfamily a, polypeptide 62

decreases expression

muraglitazar results in decreased expression of CYP3A62 mRNA

NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833

G

cytochrome P450, family 4, subfamily a, polypeptide 1

increases expression

muraglitazar results in increased expression of CYP4A1 mRNA

NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464

G

cytochrome P450, family 4, subfamily a, polypeptide 2

increases expression

muraglitazar results in increased expression of CYP4A2 mRNA

NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165

G

cytochrome P450, family 4, subfamily a, polypeptide 3

increases expression

muraglitazar results in increased expression of CYP4A3 mRNA

NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463

G

cytochrome P450, family 4, subfamily a, polypeptide 8

increases expression

muraglitazar results in increased expression of CYP4A8 mRNA

NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476

G

cytochrome P450, family 4, subfamily b, polypeptide 1

increases expression

muraglitazar results in increased expression of CYP4B1 mRNA

NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348

G

cytochrome P450, family 4, subfamily f, polypeptide 5

decreases expression

muraglitazar results in decreased expression of CYP4F5 mRNA

NCBI chr 7:11,544,040...11,558,982
Ensembl chr 7:11,544,082...11,558,978

G

cytochrome P450 family 7 subfamily A member 1

increases expression

muraglitazar results in increased expression of CYP7A1 mRNA

NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688

G

cytochrome P450 family 8 subfamily B member 1

increases expression

muraglitazar results in increased expression of CYP8B1 mRNA

NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166

G

doublecortin-like kinase 1

decreases expression

muraglitazar results in decreased expression of DCLK1 mRNA

NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956

G

DNA-damage-inducible transcript 4

increases expression

muraglitazar results in increased expression of DDIT4 mRNA

NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105

G

2,4-dienoyl-CoA reductase 1

increases expression

muraglitazar results in increased expression of DECR1 mRNA

NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018

G

2,4-dienoyl-CoA reductase 2

increases expression

muraglitazar results in increased expression of DECR2 mRNA

NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479

G

defensin beta 1

increases expression

muraglitazar results in increased expression of DEFB1 mRNA

NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604

G

dihydroorotate dehydrogenase

increases expression

muraglitazar results in increased expression of DHODH mRNA

NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654

G

dehydrogenase/reductase 3

increases expression

muraglitazar results in increased expression of DHRS3 mRNA

NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417

G

dehydrogenase/reductase 4

increases expression

muraglitazar results in increased expression of DHRS4 mRNA

NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127

G

divergent protein kinase domain 2A

increases expression

muraglitazar results in increased expression of DIPK2A mRNA

NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815

G

DnaJ heat shock protein family (Hsp40) member B7

decreases expression

muraglitazar results in decreased expression of DNAJB7 mRNA

NCBI chr 7:112,932,736...112,934,050
Ensembl chr 7:112,932,616...112,945,537

G

DnaJ heat shock protein family (Hsp40) member C5 gamma

decreases expression

muraglitazar results in decreased expression of DNAJC5G mRNA

NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152

G

deoxyribonuclease 1L3

increases expression

muraglitazar results in increased expression of DNASE1L3 mRNA

NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317

G

dual specificity phosphatase 6

decreases expression

muraglitazar results in decreased expression of DUSP6 mRNA

NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185

G

enoyl-CoA hydratase 1

multiple interactions
increases expression

[Oleic Acid co-treated with muraglitazar] results in increased expression of ECH1 mRNA
muraglitazar results in increased expression of ECH1 mRNA

PMID:21515302 PMID:24534255

NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795

G

enoyl-CoA delta isomerase 1

increases expression

muraglitazar results in increased expression of ECI1 mRNA

NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061

G

enoyl-CoA delta isomerase 2

increases expression

muraglitazar results in increased expression of ECI2 mRNA

NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781

G

egl-9 family hypoxia-inducible factor 1

increases expression

muraglitazar results in increased expression of EGLN1 mRNA

NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777

G

early growth response 1

decreases expression

muraglitazar results in decreased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

increases expression

muraglitazar results in increased expression of EHHADH mRNA

NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188

G

ELOVL fatty acid elongase 6

increases expression

muraglitazar results in increased expression of ELOVL6 mRNA

NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186

G

epoxide hydrolase 2

increases expression

muraglitazar results in increased expression of EPHX2 mRNA

NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615

G

glutamate-rich 6

decreases expression

muraglitazar results in decreased expression of ERICH6 mRNA

NCBI chr 2:142,851,905...142,878,010
Ensembl chr 2:142,851,905...142,884,320

G

electron transfer flavoprotein dehydrogenase

increases expression

muraglitazar results in increased expression of ETFDH mRNA

NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745

G

coagulation factor V

decreases expression

muraglitazar results in decreased expression of F5 mRNA

NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317

G

fatty acid binding protein 1

increases expression

muraglitazar results in increased expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

fatty acid binding protein 4

increases expression

muraglitazar results in increased expression of FABP4 mRNA

NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578

G

fumarylacetoacetate hydrolase domain containing 1

increases expression

muraglitazar results in increased expression of FAHD1 mRNA

NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012

G

family with sequence similarity 13, member A

increases expression

muraglitazar results in increased expression of FAM13A mRNA

NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860

G

family with sequence similarity 149, member A

decreases expression

muraglitazar results in decreased expression of FAM149A mRNA

NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066

G

family with sequence similarity 162, member A

increases expression

muraglitazar results in increased expression of FAM162A mRNA

NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239

G

fructose-bisphosphatase 1

increases expression

muraglitazar results in increased expression of FBP1 mRNA

NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071

G

fructose-bisphosphatase 2

increases expression

muraglitazar results in increased expression of FBP2 mRNA

NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698

G

F-box protein 32

decreases expression

muraglitazar results in decreased expression of FBXO32 mRNA

NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436

G

f-box protein 9

increases expression

muraglitazar results in increased expression of FBXO9 mRNA

NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949

G

fibroblast growth factor 21

increases expression

muraglitazar results in increased expression of FGF21 mRNA

NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454

G

FGR proto-oncogene, Src family tyrosine kinase

increases expression

muraglitazar results in increased expression of FGR mRNA

NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326

G

fin bud initiation factor homolog

increases expression

muraglitazar results in increased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

fidgetin-like 1

increases expression

muraglitazar results in increased expression of FIGNL1 mRNA

NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455

G

flavin containing dimethylaniline monoxygenase 1

decreases expression

muraglitazar results in decreased expression of FMO1 mRNA

NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647

G

FOS like 1, AP-1 transcription factor subunit

decreases expression

muraglitazar results in decreased expression of FOSL1 mRNA

NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930

G

forkhead box I2

increases expression

muraglitazar results in increased expression of FOXI2 mRNA

NCBI chr 1:190,222,857...190,226,657
Ensembl chr 1:190,222,703...190,226,433

G

forkhead box J1

decreases expression

muraglitazar results in decreased expression of FOXJ1 mRNA

NCBI chr10:101,566,299...101,570,370
Ensembl chr10:101,566,304...101,570,237

G

FERM domain containing 4B

decreases expression

muraglitazar results in decreased expression of FRMD4B mRNA

NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197

G

FERM domain containing 6

decreases expression

muraglitazar results in decreased expression of FRMD6 mRNA

NCBI chr 6:89,345,983...89,419,579
Ensembl chr 6:89,346,035...89,419,579

G

formimidoyltransferase cyclodeaminase

increases expression

muraglitazar results in increased expression of FTCD mRNA

NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735

G

fucosyltransferase 1

increases expression

muraglitazar results in increased expression of FUT1 mRNA

NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616

G

FXYD domain-containing ion transport regulator 5

decreases expression

muraglitazar results in decreased expression of FXYD5 mRNA

NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519

G

G0/G1switch 2

increases expression

muraglitazar results in increased expression of G0S2 mRNA

NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451

G

glucose-6-phosphatase catalytic subunit 1

increases expression

muraglitazar results in increased expression of G6PC1 mRNA

NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804

G

UDP-galactose-4-epimerase

increases expression

muraglitazar results in increased expression of GALE mRNA

NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388

G

polypeptide N-acetylgalactosaminyltransferase 16

decreases expression

muraglitazar results in decreased expression of GALNT16 mRNA

NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705

G

glucokinase regulator

increases expression

muraglitazar results in increased expression of GCKR mRNA

NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654

G

GDNF family receptor alpha 1

decreases expression

muraglitazar results in decreased expression of GFRA1 mRNA

NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473

G

gap junction protein, beta 3

decreases expression

muraglitazar results in decreased expression of GJB3 mRNA

NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980

G

glycerol kinase

increases expression

muraglitazar results in increased expression of GK mRNA

NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631

G

glutaredoxin

increases expression

muraglitazar results in increased expression of GLRX mRNA

NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680

G

G protein subunit alpha transducin 3

increases expression

muraglitazar results in increased expression of GNAT3 mRNA

NCBI chr 4:17,162,500...17,212,283
Ensembl chr 4:17,162,490...17,212,283

G

glutamic-oxaloacetic transaminase 1-like 1

decreases expression

muraglitazar results in decreased expression of GOT1L1 mRNA

NCBI chr16:64,860,308...64,873,656
Ensembl chr16:64,860,704...64,866,162

G

glycerol-3-phosphate acyltransferase, mitochondrial

increases expression

muraglitazar results in increased expression of GPAM mRNA

NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639

G

glypican 3

increases expression

muraglitazar results in increased expression of GPC3 mRNA

NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798

G

glycerol-3-phosphate dehydrogenase 2

increases expression

muraglitazar results in increased expression of GPD2 mRNA

NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901

G

G protein-coupled receptor 18

decreases expression

muraglitazar results in decreased expression of GPR18 mRNA

NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470

G

G protein-coupled receptor 183

decreases expression

muraglitazar results in decreased expression of GPR183 mRNA

NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559

G

glutamic--pyruvic transaminase

increases expression

muraglitazar results in increased expression of GPT mRNA

NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494

G

gelsolin

increases expression

muraglitazar results in increased expression of GSN mRNA

NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402

G

glutathione S-transferase pi 1

decreases expression

muraglitazar results in decreased expression of GSTP1 mRNA

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

glycogen synthase 1

increases expression

muraglitazar results in increased expression of GYS1 mRNA

NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292

G

glycogen synthase 2

increases expression

muraglitazar results in increased expression of GYS2 mRNA

NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228

G

H1.0 linker histone

increases expression

muraglitazar results in increased expression of H1F0 mRNA

NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694

G

2-hydroxyacyl-CoA lyase 1

increases expression

muraglitazar results in increased expression of HACL1 mRNA

NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027

G

hydroxyacyl-CoA dehydrogenase

increases expression

muraglitazar results in increased expression of HADH mRNA

NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

increases expression

muraglitazar results in increased expression of HADHA mRNA

NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta

increases expression

muraglitazar results in increased expression of HADHB mRNA

NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869

G

hepcidin antimicrobial peptide

decreases expression

muraglitazar results in decreased expression of HAMP mRNA

NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891

G

hyaluronan and proteoglycan link protein 2

decreases expression

muraglitazar results in decreased expression of HAPLN2 mRNA

NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588

G

heparin-binding EGF-like growth factor

decreases expression

muraglitazar results in decreased expression of HBEGF mRNA

NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441

G

hydroxycarboxylic acid receptor 2

decreases expression

muraglitazar results in decreased expression of HCAR2 mRNA

NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504

G

histone deacetylase 7

decreases expression

muraglitazar results in decreased expression of HDAC7 mRNA

NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072

G

3-hydroxyisobutyryl-CoA hydrolase

increases expression

muraglitazar results in increased expression of HIBCH mRNA

NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

increases expression

muraglitazar results in increased expression of HMGCS2 mRNA

NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130

G

hydroxysteroid (17-beta) dehydrogenase 2

increases expression

muraglitazar results in increased expression of HSD17B2 mRNA

NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202

G

hydroxysteroid (17-beta) dehydrogenase 4

increases expression

muraglitazar results in increased expression of HSD17B4 mRNA

NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

decreases expression

muraglitazar results in decreased expression of HSD3B1 mRNA

NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999

G

hydroxysteroid dehydrogenase like 2

increases expression

muraglitazar results in increased expression of HSDL2 mRNA

NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839

G

heat shock protein family D (Hsp60) member 1, pseudogene 13

increases expression

muraglitazar results in increased expression of HSPD1-PS13 mRNA

NCBI chr 9:46,991,457...46,996,798

G

heat shock protein family D (Hsp60) member 1, pseudogene 6

increases expression

muraglitazar results in increased expression of HSPD1-PS6 mRNA

NCBI chr20:31,367,312...31,370,199

G

heat shock protein family D (Hsp60) member 1, pseudogene 7

increases expression

muraglitazar results in increased expression of HSPD1-PS7 mRNA

NCBI chr 1:103,645,663...103,648,170

G

intercellular adhesion molecule 1

decreases expression

muraglitazar results in decreased expression of ICAM1 mRNA

NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438

G

inhibitor of DNA binding 1

increases expression

muraglitazar results in increased expression of ID1 mRNA

NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419

G

immediate early response 5-like

increases expression

muraglitazar results in increased expression of IER5L mRNA

NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647

G

insulin-like growth factor binding protein 3

increases expression

muraglitazar results in increased expression of IGFBP3 mRNA

NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083

G

interleukin 18 receptor accessory protein

decreases expression

muraglitazar results in decreased expression of IL18RAP mRNA

NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959

G

interleukin 1 beta

decreases expression

muraglitazar results in decreased expression of IL1B mRNA

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 1 receptor type 1

decreases expression

muraglitazar results in decreased expression of IL1R1 mRNA

NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937

G

interleukin 1 receptor type 2

decreases expression

muraglitazar results in decreased expression of IL1R2 mRNA

NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725

G

interleukin 1 receptor-like 1

decreases expression

muraglitazar results in decreased expression of IL1RL1 mRNA

NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256

G

interleukin 33

decreases expression

muraglitazar results in decreased expression of IL33 mRNA

NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373

G

inositol monophosphatase 2

increases expression

muraglitazar results in increased expression of IMPA2 mRNA

NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641

G

inhibin subunit beta C

increases expression

muraglitazar results in increased expression of INHBC mRNA

NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630

G

ISL LIM homeobox 1

decreases expression

muraglitazar results in decreased expression of ISL1 mRNA

NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584

G

integrin subunit alpha 2

decreases expression

muraglitazar results in decreased expression of ITGA2 mRNA

NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481

G

jagged canonical Notch ligand 2

decreases expression

muraglitazar results in decreased expression of JAG2 mRNA

NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818

G

JunB proto-oncogene, AP-1 transcription factor subunit

decreases expression

muraglitazar results in decreased expression of JUNB mRNA

NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035

G

potassium voltage-gated channel modifier subfamily G member 1

decreases expression

muraglitazar results in decreased expression of KCNG1 mRNA

NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:156,973,156...156,992,635

G

potassium voltage-gated channel modifier subfamily G member 3

decreases expression

muraglitazar results in decreased expression of KCNG3 mRNA

NCBI chr 6:11,051,311...11,099,264
Ensembl chr 6:11,051,134...11,099,264

G

potassium inwardly-rectifying channel, subfamily J, member 4

decreases expression

muraglitazar results in decreased expression of KCNJ4 mRNA

NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151

G

potassium inwardly-rectifying channel, subfamily J, member 8

increases expression

muraglitazar results in increased expression of KCNJ8 mRNA

NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603

G

potassium two pore domain channel subfamily K member 2

increases expression

muraglitazar results in increased expression of KCNK2 mRNA

NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435

G

potassium voltage-gated channel, modifier subfamily S, member 3

decreases expression

muraglitazar results in decreased expression of KCNS3 mRNA

NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125

G

kinesin family member 12

decreases expression

muraglitazar results in decreased expression of KIF12 mRNA

NCBI chr 5:76,596,204...76,603,261
Ensembl chr 5:76,596,208...76,602,843

G

KLF transcription factor 15

increases expression

muraglitazar results in increased expression of KLF15 mRNA

NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374

G

kallikrein 1-related peptidase C6

decreases expression

muraglitazar results in decreased expression of KLK1C6 mRNA

NCBI chr 1:94,467,626...94,475,842
Ensembl chr 1:94,467,672...94,475,806

G

killer cell lectin like receptor B1A

decreases expression

muraglitazar results in decreased expression of KLRB1A mRNA

NCBI chr 4:161,890,577...161,904,050
Ensembl chr 4:161,890,577...161,961,675

G

kynurenine 3-monooxygenase

decreases expression

muraglitazar results in decreased expression of KMO mRNA

NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881

G

keratin 20

decreases expression

muraglitazar results in decreased expression of KRT20 mRNA

NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107

G

lactamase, beta 2

increases expression

muraglitazar results in increased expression of LACTB2 mRNA

NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429

G

lipocalin 2

decreases expression

muraglitazar results in decreased expression of LCN2 mRNA

NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095

G

liver enriched antimicrobial peptide 2

decreases expression

muraglitazar results in decreased expression of LEAP2 mRNA

NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244

G

lipase E, hormone sensitive type

increases expression

muraglitazar results in increased expression of LIPE mRNA

NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310

G

lipase H

decreases expression

muraglitazar results in decreased expression of LIPH mRNA

NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625

G

leiomodin 2

increases expression

muraglitazar results in increased expression of LMOD2 mRNA

NCBI chr 4:53,067,428...53,075,124
Ensembl chr 4:53,067,428...53,075,120

G

lon peptidase 2, peroxisomal

increases expression

muraglitazar results in increased expression of LONP2 mRNA

NCBI chr19:20,407,475...20,498,985
Ensembl chr19:20,407,477...20,499,014

G

lysyl oxidase-like 1

decreases expression

muraglitazar results in decreased expression of LOXL1 mRNA

NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356

G

lysophosphatidylcholine acyltransferase 3

increases expression

muraglitazar results in increased expression of LPCAT3 mRNA

NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880

G

lecithin retinol acyltransferase

increases expression

muraglitazar results in increased expression of LRAT mRNA

NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619

G

LDL receptor related protein 1

increases expression

muraglitazar results in increased expression of LRP1 mRNA

NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910

G

lymphotoxin beta

affects expression

muraglitazar affects the expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381

G

latent transforming growth factor beta binding protein 1

increases expression

muraglitazar results in increased expression of LTBP1 mRNA

NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349

G

latexin

decreases expression

muraglitazar results in decreased expression of LXN mRNA

NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460

G

Ly49 inhibitory receptor 4

decreases expression

muraglitazar results in decreased expression of LY49I4 mRNA

NCBI chr 4:164,166,784...164,188,380
Ensembl chr 4:164,122,072...164,341,692

G

lymphocyte antigen 6 complex, locus I

increases expression

muraglitazar results in increased expression of LY6B mRNA

NCBI chr 7:107,062,320...107,067,743
Ensembl chr 7:107,062,325...107,067,310

G

lysozyme C type 2

decreases expression

muraglitazar results in decreased expression of LYC2 mRNA

NCBI chr 7:52,887,104...52,894,447
Ensembl chr 7:52,886,883...52,894,446

G

lysozyme 2

decreases expression

muraglitazar results in decreased expression of LYZ mRNA

NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106

G

mal, T-cell differentiation protein-like

increases expression

muraglitazar results in increased expression of MALL mRNA

NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785

G

methionine adenosyltransferase 1A

increases expression

muraglitazar results in increased expression of MAT1A mRNA

NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274

G

mucolipin TRP cation channel 3

increases expression

muraglitazar results in increased expression of MCOLN3 mRNA

NCBI chr 2:235,008,716...235,042,885
Ensembl chr 2:234,966,010...235,043,047

G

monoglyceride lipase

increases expression

muraglitazar results in increased expression of MGLL mRNA

NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179

G

matrix Gla protein

decreases expression

muraglitazar results in decreased expression of MGP mRNA

NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667

G

myo-inositol oxygenase

increases expression

muraglitazar results in increased expression of MIOX mRNA

NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537

G

microRNA 16

increases expression

muraglitazar results in increased expression of MIR16 mRNA

NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443

G

malonyl-CoA decarboxylase

increases expression

muraglitazar results in increased expression of MLYCD mRNA

NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793

G

matrix metallopeptidase 10

decreases expression

muraglitazar results in decreased expression of MMP10 mRNA

NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748

G

matrix metallopeptidase 3

decreases expression

muraglitazar results in decreased expression of MMP3 mRNA

NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961

G

meiosis-specific nuclear structural 1

decreases expression

muraglitazar results in decreased expression of MNS1 mRNA

NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925

G

molybdenum cofactor synthesis 2

increases expression

muraglitazar results in increased expression of MOCS2 mRNA

NCBI chr 2:46,504,588...46,516,327
Ensembl chr 2:46,504,588...46,516,324

G

MORN repeat containing 4

decreases expression

muraglitazar results in decreased expression of MORN4 mRNA

NCBI chr 1:240,888,338...240,898,644
Ensembl chr 1:240,888,344...240,898,716

G

msh homeobox 2

increases expression

muraglitazar results in increased expression of MSX2 mRNA

NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879

G

microsomal triglyceride transfer protein

increases expression

muraglitazar results in increased expression of MTTP mRNA

NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239

G

mucin 13, cell surface associated

increases expression

muraglitazar results in increased expression of MUC13 mRNA

NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727

G

mucin 2, oligomeric mucus/gel-forming

decreases expression

muraglitazar results in decreased expression of MUC2 mRNA

NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756

G

NEDD4 binding protein 2-like 1

increases expression

muraglitazar results in increased expression of N4BP2L1 mRNA

NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257

G

N-acyl phosphatidylethanolamine phospholipase D

increases expression

muraglitazar results in increased expression of NAPEPLD mRNA

NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748

G

N-myc downstream regulated 1

increases expression

muraglitazar results in increased expression of NDRG1 mRNA

NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880

G

neurofilament medium chain

decreases expression

muraglitazar results in decreased expression of NEFM mRNA

NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755

G

neural EGFL like 2

decreases expression

muraglitazar results in decreased expression of NELL2 mRNA

NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503

G

NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor

decreases expression

muraglitazar results in decreased expression of NF2 mRNA

NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667

G

nuclear factor kappa B subunit 1

decreases expression

muraglitazar results in decreased expression of NFKB1 mRNA

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404

G

nuclear factor kappa B subunit 2

decreases expression

muraglitazar results in decreased expression of NFKB2 mRNA

NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213

G

nidogen 2

increases expression

muraglitazar results in increased expression of NID2 mRNA

NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843

G

nucleotide-binding oligomerization domain containing 2

decreases expression

muraglitazar results in decreased expression of NOD2 mRNA

NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177

G

NOVA alternative splicing regulator 1

increases expression

muraglitazar results in increased expression of NOVA1 mRNA

NCBI chr 6:63,780,105...63,905,567
Ensembl chr 6:63,783,489...63,906,289

G

NPC1 like intracellular cholesterol transporter 1

increases expression

muraglitazar results in increased expression of NPC1L1 mRNA

NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113

G

neuropeptide Y

decreases expression

muraglitazar results in decreased expression of NPY mRNA

NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495

G

nuclear receptor subfamily 1, group H, member 3

multiple interactions

[Oleic Acid co-treated with muraglitazar] results in increased expression of NR1H3 mRNA

NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722

G

nuclear receptor subfamily 1, group H, member 4

multiple interactions

[Oleic Acid co-treated with muraglitazar] results in increased expression of NR1H4 mRNA

NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047

G

nuclear receptor subfamily 1, group I, member 3

increases expression
multiple interactions

muraglitazar results in increased expression of NR1I3 mRNA
[Oleic Acid co-treated with muraglitazar] results in increased expression of NR1I3 mRNA

PMID:21515302 PMID:24534255

NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906

G

nuclear receptor subfamily 4, group A, member 1

decreases expression

muraglitazar results in decreased expression of NR4A1 mRNA

NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297

G

neuropilin 2

decreases expression

muraglitazar results in decreased expression of NRP2 mRNA

NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958

G

neurotrophic receptor tyrosine kinase 1

increases expression

muraglitazar results in increased expression of NTRK1 mRNA

NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770

G

ornithine aminotransferase

increases expression

muraglitazar results in increased expression of OAT mRNA

NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682

G

odorant binding protein I f

increases expression

muraglitazar results in increased expression of OBP1F mRNA

NCBI chr X:41,955,618...41,960,681
Ensembl chr X:41,955,618...41,960,681

G

oncoprotein induced transcript 3

decreases expression

muraglitazar results in decreased expression of OIT3 mRNA

NCBI chr20:27,390,113...27,410,692
Ensembl chr20:27,390,113...27,410,692

G

olfactory receptor pseudogene 981

decreases expression

muraglitazar results in decreased expression of OLR981-PS mRNA

NCBI chr 7:4,448,410...4,449,130

G

5-oxoprolinase (ATP-hydrolysing)

increases expression

muraglitazar results in increased expression of OPLAH mRNA

NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297

G

oxysterol binding protein-like 5

decreases expression

muraglitazar results in decreased expression of OSBPL5 mRNA

NCBI chr 1:198,862,071...198,916,469
Ensembl chr 1:198,862,055...198,916,469

G

osteocrin

decreases expression

muraglitazar results in decreased expression of OSTN mRNA

NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603

G

prostate androgen-regulated mucin-like protein 1

increases expression

muraglitazar results in increased expression of PARM1 mRNA

NCBI chr14:16,468,309...16,577,339
Ensembl chr14:16,468,459...16,577,314

G

PATJ, crumbs cell polarity complex component

increases expression

muraglitazar results in increased expression of PATJ mRNA

NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807

G

phenazine biosynthesis-like protein domain containing 1

decreases expression

muraglitazar results in decreased expression of PBLD mRNA

NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614

G

pyruvate carboxylase

increases expression

muraglitazar results in increased expression of PC mRNA

NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380

G

phosphoenolpyruvate carboxykinase 1

increases expression

muraglitazar results in increased expression of PCK1 mRNA

NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191

G

phosphodiesterase 1A

decreases expression

muraglitazar results in decreased expression of PDE1A mRNA

NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874

G

platelet derived growth factor receptor beta

increases expression

muraglitazar results in increased expression of PDGFRB mRNA

NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843

G

pyruvate dehydrogenase kinase 4

increases expression

muraglitazar results in increased expression of PDK4 mRNA

NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850

G

pyridoxal kinase like 1

increases expression

muraglitazar results in increased expression of PDXK mRNA

NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739

G

PDZ domain containing 1

increases expression

muraglitazar results in increased expression of PDZK1 mRNA

NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514

G

proliferation and apoptosis adaptor protein 15

decreases expression

muraglitazar results in decreased expression of PEA15 mRNA

NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499

G

peroxisomal biogenesis factor 11 alpha

increases expression

muraglitazar results in increased expression of PEX11A mRNA

NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172

G

peroxisomal biogenesis factor 16

increases expression

muraglitazar results in increased expression of PEX16 mRNA

NCBI chr 3:78,347,212...78,352,603
Ensembl chr 3:78,343,164...78,353,207

G

peroxisomal biogenesis factor 19

increases expression

muraglitazar results in increased expression of PEX19 mRNA

NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608

G

phosphofructokinase, liver type

increases expression

muraglitazar results in increased expression of PFKL mRNA

NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315

G

phosphoglycerate kinase 1

increases expression

muraglitazar results in increased expression of PGK1 mRNA

NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418

G

progesterone receptor membrane component 2

increases expression

muraglitazar results in increased expression of PGRMC2 mRNA

NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155

G

pleckstrin homology-like domain, family A, member 1

decreases expression

muraglitazar results in decreased expression of PHLDA1 mRNA

NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861

G

pleckstrin homology-like domain, family B, member 1

decreases expression

muraglitazar results in decreased expression of PHLDB1 mRNA

NCBI chr 8:45,003,543...45,051,541
Ensembl chr 8:45,003,538...45,051,522

G

phytanoyl-CoA 2-hydroxylase

increases expression

muraglitazar results in increased expression of PHYH mRNA

NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409

G

phospholipase A1 member A

decreases expression

muraglitazar results in decreased expression of PLA1A mRNA

NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779

G

phospholipase A and acyltransferase 3

decreases expression

muraglitazar results in decreased expression of PLAAT3 mRNA

NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667

G

phospholipase B domain containing 1

increases expression

muraglitazar results in increased expression of PLBD1 mRNA

NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277

G

pleckstrin homology domain containing O1

decreases expression

muraglitazar results in decreased expression of PLEKHO1 mRNA

NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785

G

perilipin 2

multiple interactions

muraglitazar promotes the reaction [Oleic Acid results in increased expression of PLIN2 mRNA]

NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319

G

perilipin 4

multiple interactions

muraglitazar promotes the reaction [Oleic Acid results in increased expression of PLIN4 mRNA]

NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056

G

perilipin 5

increases expression

muraglitazar results in increased expression of PLIN5 mRNA

NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120

G

phospholipid scramblase 2

decreases expression

muraglitazar results in decreased expression of PLSCR2 mRNA

NCBI chr 8:92,809,422...92,845,947
Ensembl chr 8:92,808,398...92,845,932

G

cytochrome p450 oxidoreductase

increases expression

muraglitazar results in increased expression of POR mRNA

NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245

G

peroxisome proliferator activated receptor alpha

increases expression
multiple interactions

muraglitazar results in increased expression of PPARA mRNA
muraglitazar binds to and results in increased activity of PPARA protein

PMID:17426106 PMID:17675651 PMID:21515302

NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346

G

peroxisome proliferator-activated receptor gamma

multiple interactions
decreases expression

muraglitazar binds to and results in increased activity of PPARG protein
muraglitazar results in decreased expression of PPARG mRNA

PMID:17426106 PMID:17675651 PMID:21515302

NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468

G

phosphopantothenoylcysteine synthetase

increases expression

muraglitazar results in increased expression of PPCS mRNA

NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933

G

protamine 2

decreases expression

muraglitazar results in decreased expression of PRM2 mRNA

NCBI chr10:4,876,285...4,877,026
Ensembl chr10:4,873,372...4,877,026

G

prominin 1

decreases expression

muraglitazar results in decreased expression of PROM1 mRNA

NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527

G

serine protease 8

decreases expression

muraglitazar results in decreased expression of PRSS8 mRNA

NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815

G

phosphoserine aminotransferase 1

increases expression

muraglitazar results in increased expression of PSAT1 mRNA

NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682

G

PX domain containing 1

decreases expression

muraglitazar results in decreased expression of PXDC1 mRNA

NCBI chr17:30,275,998...30,304,971
Ensembl chr17:30,276,377...30,304,973

G

glycogen phosphorylase L

increases expression

muraglitazar results in increased expression of PYGL mRNA

NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310

G

pyroglutamylated RFamide peptide receptor

decreases expression

muraglitazar results in decreased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792

G

RAB19, member RAS oncogene family

decreases expression

muraglitazar results in decreased expression of RAB19 mRNA

NCBI chr 4:68,157,159...68,166,889
Ensembl chr 4:68,156,881...68,166,886

G

RAB9A, member RAS oncogene family

increases expression

muraglitazar results in increased expression of RAB9 mRNA

NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622

G

retinoic acid induced 14

decreases expression

muraglitazar results in decreased expression of RAI14 mRNA

NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971

G

receptor activity modifying protein 1

increases expression

muraglitazar results in increased expression of RAMP1 mRNA

NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151

G

RAS p21 protein activator 3

decreases expression

muraglitazar results in decreased expression of RASA3 mRNA

NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804

G

Ras association domain family member 9

decreases expression

muraglitazar results in decreased expression of RASSF9 mRNA

NCBI chr 7:37,599,720...37,631,553
Ensembl chr 7:37,599,720...37,635,245

G

REST corepressor 2

increases expression

muraglitazar results in increased expression of RCOR2 mRNA

NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838

G

REC8 meiotic recombination protein

increases expression

muraglitazar results in increased expression of REC8 mRNA

NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326

G

regenerating family member 4

decreases expression

muraglitazar results in decreased expression of REG4 mRNA

NCBI chr 2:185,818,946...185,833,252
Ensembl chr 2:185,821,210...185,833,353

G

retinol saturase

increases expression

muraglitazar results in increased expression of RETSAT mRNA

NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310

G

regulator of G-protein signaling 2

decreases expression

muraglitazar results in decreased expression of RGS2 mRNA

NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385

G

regulator of G-protein signaling 4

increases expression

muraglitazar results in increased expression of RGS4 mRNA

NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068

G

ribonuclease A family member 1, pancreatic

decreases expression

muraglitazar results in decreased expression of RNASE1 mRNA

NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624

G

ribonuclease A family member 3

decreases expression

muraglitazar results in decreased expression of RNASE3 mRNA

NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790

G

rhophilin associated tail protein 1-like

decreases expression

muraglitazar results in decreased expression of ROPN1L mRNA

NCBI chr 2:82,442,645...82,453,332
Ensembl chr 2:82,441,891...82,453,485

G

RT1 class Ib, locus M3, gene 1

decreases expression

muraglitazar results in decreased expression of RT1-M3-1 mRNA

NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117

G

RUNX family transcription factor 1

decreases expression

muraglitazar results in decreased expression of RUNX1 mRNA

NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542

G

relaxin family peptide receptor 2

decreases expression

muraglitazar results in decreased expression of RXFP2 mRNA

NCBI chr12:4,924,747...4,986,672
Ensembl chr12:4,925,722...4,986,596

G

retinoid X receptor gamma

increases expression

muraglitazar results in increased expression of RXRG mRNA

NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167

G

S100 calcium binding protein A1

decreases expression

muraglitazar results in decreased expression of S100A1 mRNA

NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544

G

S100 calcium binding protein A6

decreases expression

muraglitazar results in decreased expression of S100A6 mRNA

NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180

G

stearoyl-CoA desaturase

multiple interactions
increases expression

[Oleic Acid co-treated with muraglitazar] results in increased expression of SCD1 mRNA
muraglitazar results in increased expression of SCD1 mRNA

PMID:21515302 PMID:24534255

NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562

G

sodium voltage-gated channel alpha subunit 3

decreases expression

muraglitazar results in decreased expression of SCN3A mRNA

NCBI chr 3:50,146,411...50,258,119
Ensembl chr 3:50,148,139...50,258,119

G

stimulator of chondrogenesis 1

decreases expression

muraglitazar results in decreased expression of SCRG1 mRNA

NCBI chr16:32,760,028...32,788,299
Ensembl chr16:32,760,028...32,788,299

G

selenoprotein P

decreases expression

muraglitazar results in decreased expression of SELENOP mRNA

NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852

G

semaphorin 4A

decreases expression

muraglitazar results in decreased expression of SEMA4A mRNA

NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442

G

serine incorporator 2

decreases expression

muraglitazar results in decreased expression of SERINC2 mRNA

NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364

G

serpin family B member 5

increases expression

muraglitazar results in increased expression of SERPINB5 mRNA

NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756

G

serpin family E member 1

increases expression

muraglitazar results in increased expression of SERPINE1 mRNA

NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657

G

serpin family E member 2

increases expression

muraglitazar results in increased expression of SERPINE2 mRNA

NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826

G

sideroflexin 3

decreases expression

muraglitazar results in decreased expression of SFXN3 mRNA

NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073

G

sarcoglycan, gamma

decreases expression

muraglitazar results in decreased expression of SGCG mRNA

NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148

G

signal-regulatory protein alpha

decreases expression

muraglitazar results in decreased expression of SIRPA mRNA

NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098

G

SLAIN motif family, member 1

decreases expression

muraglitazar results in decreased expression of SLAIN1 mRNA

NCBI chr15:80,482,818...80,542,461
Ensembl chr15:80,482,367...80,542,350

G

solute carrier family 10 member 2

decreases expression

muraglitazar results in decreased expression of SLC10A2 mRNA

NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475

G

solute carrier family 12 member 1

decreases expression

muraglitazar results in decreased expression of SLC12A1 mRNA

NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899

G

solute carrier family 17 member 8

decreases expression

muraglitazar results in decreased expression of SLC17A8 mRNA

NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079

G

solute carrier family 22 member 22

decreases expression

muraglitazar results in decreased expression of SLC22A22 mRNA

NCBI chr 7:88,720,425...88,750,111
Ensembl chr 7:88,720,427...88,750,111

G

solute carrier family 22 member 5

increases expression

muraglitazar results in increased expression of SLC22A5 mRNA

NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309

G

solute carrier family 24 member 2

decreases expression

muraglitazar results in decreased expression of SLC24A2 mRNA

NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337

G

solute carrier family 25 member 20

increases expression

muraglitazar results in increased expression of SLC25A20 mRNA

NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512

G

solute carrier family 25, member 34

increases expression

muraglitazar results in increased expression of SLC25A34 mRNA

NCBI chr 5:153,932,081...153,936,854

G

solute carrier family 25, member 42

increases expression

muraglitazar results in increased expression of SLC25A42 mRNA

NCBI chr16:19,213,914...19,251,990
Ensembl chr16:19,213,950...19,237,025

G

solute carrier family 27 member 2

increases expression

muraglitazar results in increased expression of SLC27A2 mRNA

NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208

G

solute carrier family 2 member 2

decreases expression

muraglitazar results in decreased expression of SLC2A2 mRNA

NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933

G

solute carrier family 30 member 2

increases expression

muraglitazar results in increased expression of SLC30A2 mRNA

NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956

G

solute carrier family 34 member 2

increases expression

muraglitazar results in increased expression of SLC34A2 mRNA

NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436

G

solute carrier family 34 member 3

decreases expression

muraglitazar results in decreased expression of SLC34A3 mRNA

NCBI chr 3:8,044,294...8,050,034
Ensembl chr 3:8,044,296...8,049,970

G

solute carrier family 46, member 3

decreases expression

muraglitazar results in decreased expression of SLC46A3 mRNA

NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092

G

solute carrier family 4 member 4

increases expression

muraglitazar results in increased expression of SLC4A4 mRNA

NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883

G

solute carrier family 6 member 13

increases expression

muraglitazar results in increased expression of SLC6A13 mRNA

NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152

G

solute carrier family 6 member 18

decreases expression

muraglitazar results in decreased expression of SLC6A18 mRNA

NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925

G

solute carrier organic anion transporter family, member 1a4

increases expression

muraglitazar results in increased expression of SLCO1A4 mRNA

NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573

G

solute carrier organic anion transporter family, member 3a1

decreases expression

muraglitazar results in decreased expression of SLCO3A1 mRNA

NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925

G

slit guidance ligand 2

decreases expression

muraglitazar results in decreased expression of SLIT2 mRNA

NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948

G

SMAD family member 3

decreases expression

muraglitazar results in decreased expression of SMAD3 mRNA

NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960

G

small integral membrane protein 3

decreases expression

muraglitazar results in decreased expression of SMIM3 mRNA

NCBI chr18:53,930,019...53,982,339
Ensembl chr18:53,930,020...53,957,416

G

SPARC related modular calcium binding 1

increases expression

muraglitazar results in increased expression of SMOC1 mRNA

NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699

G

small muscle protein, X-linked

decreases expression

muraglitazar results in decreased expression of SMPX mRNA

NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708

G

sorting nexin 10

increases expression

muraglitazar results in increased expression of SNX10 mRNA

NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996

G

sterol O-acyltransferase 2

increases expression

muraglitazar results in increased expression of SOAT2 mRNA

NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915

G

sorbin and SH3 domain containing 1

increases expression

muraglitazar results in increased expression of SORBS1 mRNA

NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169

G

striated muscle enriched protein kinase

increases expression

muraglitazar results in increased expression of SPEG mRNA

NCBI chr 9:76,865,714...76,923,170
Ensembl chr 9:76,865,754...76,923,144

G

secreted phosphoprotein 1

decreases expression

muraglitazar results in decreased expression of SPP1 mRNA

NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162

G

sprouty RTK signaling antagonist 2

decreases expression

muraglitazar results in decreased expression of SPRY2 mRNA

NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009

G

splA/ryanodine receptor domain and SOCS box containing 2

decreases expression

muraglitazar results in decreased expression of SPSB2 mRNA

NCBI chr 4:157,613,404...157,615,293
Ensembl chr 4:157,613,401...157,615,284

G

sterol regulatory element binding transcription factor 1

increases expression

muraglitazar results in increased expression of SREBF1 mRNA

NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650

G

somatostatin receptor 3

decreases expression

muraglitazar results in decreased expression of SSTR3 mRNA

NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769

G

somatostatin receptor 5

increases expression

muraglitazar results in increased expression of SSTR5 mRNA

NCBI chr10:14,506,868...14,512,946
Ensembl chr10:14,506,868...14,512,946

G

stanniocalcin 2

increases expression

muraglitazar results in increased expression of STC2 mRNA

NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973

G

STEAP4 metalloreductase

decreases expression

muraglitazar results in decreased expression of STEAP4 mRNA

NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859

G

stathmin 4

decreases expression

muraglitazar results in decreased expression of STMN4 mRNA

NCBI chr15:40,541,305...40,559,253
Ensembl chr15:40,541,357...40,559,253

G

sulfatase 1

decreases expression

muraglitazar results in decreased expression of SULF1 mRNA

NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584

G

synaptotagmin-like 5

decreases expression

muraglitazar results in decreased expression of SYTL5 mRNA

NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175

G

transgelin

decreases expression

muraglitazar results in decreased expression of TAGLN mRNA

NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668

G

tyrosine aminotransferase

increases expression

muraglitazar results in increased expression of TAT mRNA

NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031

G

TBC1 domain family, member 21

decreases expression

muraglitazar results in decreased expression of TBC1D21 mRNA

NCBI chr 8:58,761,562...58,773,711
Ensembl chr 8:58,761,563...58,773,711

G

T-box transcription factor 3

increases expression

muraglitazar results in increased expression of TBX3 mRNA

NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708

G

teneurin transmembrane protein 2

increases expression

muraglitazar results in increased expression of TENM2 mRNA

NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597

G

transforming growth factor, beta 2

increases expression

muraglitazar results in increased expression of TGFB2 mRNA

NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405

G

transforming growth factor, beta 3

decreases expression

muraglitazar results in decreased expression of TGFB3 mRNA

NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564

G

transglutaminase 1

decreases expression

muraglitazar results in decreased expression of TGM1 mRNA

NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523

G

transglutaminase 2

increases expression

muraglitazar results in increased expression of TGM2 mRNA

NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981

G

translocase of inner mitochondrial membrane 10B

increases expression

muraglitazar results in increased expression of TIMM10B mRNA

NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642

G

TIMP metallopeptidase inhibitor 1

decreases expression

muraglitazar results in decreased expression of TIMP1 mRNA

NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664

G

tubulointerstitial nephritis antigen-like 1

increases expression

muraglitazar results in increased expression of TINAGL1 mRNA

NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720

G

toll-like receptor 6

decreases expression

muraglitazar results in decreased expression of TLR6 mRNA

NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685

G

transmembrane 4 L six family member 4

increases expression

muraglitazar results in increased expression of TM4SF4 mRNA

NCBI chr 2:141,570,321...141,621,263
Ensembl chr 2:141,481,902...141,621,200

G

transmembrane protein 14C

increases expression

muraglitazar results in increased expression of TMEM14C mRNA

NCBI chr17:23,733,769...23,739,906
Ensembl chr17:23,733,894...23,753,320

G

thymosin beta 4, X-linked

decreases expression

muraglitazar results in decreased expression of TMSB4X mRNA

NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667

G

thiol methyltransferase 1B

increases expression

muraglitazar results in increased expression of TMT1B mRNA

NCBI chr 7:1,388,876...1,391,526
Ensembl chr 7:1,388,879...1,391,526

G

TNF alpha induced protein 2

decreases expression

muraglitazar results in decreased expression of TNFAIP2 mRNA

NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914

G

TNF receptor superfamily member 9

increases expression

muraglitazar results in increased expression of TNFRSF9 mRNA

NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000

G

torsin family 3, member A

increases expression

muraglitazar results in increased expression of TOR3A mRNA

NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475

G

thyroid peroxidase

decreases expression

muraglitazar results in decreased expression of TPO mRNA

NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199

G

tripartite motif-containing 54

decreases expression

muraglitazar results in decreased expression of TRIM54 mRNA

NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511

G

tsukushi, small leucine rich proteoglycan

increases expression

muraglitazar results in increased expression of TSKU mRNA

NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588

G

thioredoxin interacting protein

increases expression

muraglitazar results in increased expression of TXNIP mRNA

NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886

G

uncoupling protein 2

increases expression

muraglitazar results in increased expression of UCP2 mRNA

NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611

G

UDP glucuronosyltransferase family 1 member A1

increases glucuronidation

UGT1A1 protein results in increased glucuronidation of muraglitazar

NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase 1 family, polypeptide A2

increases glucuronidation

UGT1A3 protein results in increased glucuronidation of muraglitazar

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase family 1 member A9

increases glucuronidation

UGT1A9 protein results in increased glucuronidation of muraglitazar

NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase 2 family, polypeptide B1

decreases expression

muraglitazar results in decreased expression of UGT2B1 mRNA

NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986

G

unc-5 netrin receptor B

increases expression

muraglitazar results in increased expression of UNC5B mRNA

NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537

G

USH1 protein network component harmonin

decreases expression

muraglitazar results in decreased expression of USH1C mRNA

NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671

G

ubiquitin specific peptidase 2

increases expression

muraglitazar results in increased expression of USP2 mRNA

NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331

G

integral membrane transport protein UST4r

decreases expression

muraglitazar results in decreased expression of UST4R mRNA

NCBI chr 1:205,072,204...205,142,718
Ensembl chr 1:205,072,296...205,142,691

G

vascular cell adhesion molecule 1

decreases expression

muraglitazar results in decreased expression of VCAM1 mRNA

NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958

G

vasoactive intestinal peptide receptor 1

decreases expression

muraglitazar results in decreased expression of VIPR1 mRNA

NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585

G

very low density lipoprotein receptor

increases expression

muraglitazar results in increased expression of VLDLR mRNA

NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920

G

vanin 1

increases expression

muraglitazar results in increased expression of VNN1 mRNA

NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395

G

vomeronasal 2 receptor, pseudogene 45

decreases expression

muraglitazar results in decreased expression of VOM2R-PS45 mRNA

NCBI chr 1:66,463,177...66,490,650
Ensembl chr 1:66,463,277...66,490,550

G

vomeronasal 2 receptor 44

increases expression

muraglitazar results in increased expression of VOM2R44 mRNA

NCBI chr 2:148,497,150...148,536,036
Ensembl chr 2:148,500,170...148,531,880

G

vomeronasal 2 receptor, 65

increases expression

muraglitazar results in increased expression of VOM2R65 mRNA

G

xin actin-binding repeat containing 1

decreases expression

muraglitazar results in decreased expression of XIRP1 mRNA

NCBI chr 8:119,744,778...119,757,547
Ensembl chr 8:119,747,419...119,757,349

G

yippee-like 4

decreases expression

muraglitazar results in decreased expression of YPEL4 mRNA

NCBI chr 3:69,815,373...69,820,708
Ensembl chr 3:69,816,175...69,820,707

G

zinc finger DHHC-type palmitoyltransferase 18

decreases expression

muraglitazar results in decreased expression of ZDHHC18 mRNA

NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993

G

zinc finger protein 354A

increases expression

muraglitazar results in increased expression of ZFP354A mRNA

NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068

G

zinc finger protein 365

decreases expression

muraglitazar results in decreased expression of ZFP365 mRNA

NCBI chr20:20,666,240...20,689,734
Ensembl chr20:20,666,240...20,691,238

G

zinc finger protein 37

increases expression

muraglitazar results in increased expression of ZFP37 mRNA

NCBI chr 5:75,598,732...75,638,896
Ensembl chr 5:75,598,732...75,638,942

oxaprozin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

heat shock transcription factor 1

increases activity

Oxaprozin results in increased activity of HSF1 protein

NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011

G

nerve growth factor receptor

increases expression

oxaprozin results in increased expression of NGFR protein

NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518

G

peroxisome proliferator-activated receptor gamma

increases activity

oxaprozin results in increased activity of PPARG protein

NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468

G

RT1 class II, locus Bb

affects expression

Oxaprozin affects the expression of HLA-DQB1 mRNA

NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19890
chemical entity	19867
atom	19888
nonmetal atom	19789
oxygen atom	19549
oxygen molecular entity	19529
organooxygen compound	19180
oxacycle	17917
oxazole	3646
1,3-oxazoles	797
(16alpha,20R,24R)-24N,25-carbamoyloxy-2,16,20-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside	0
(2S)-3-methyl-2-((2R,3S)-3-[(methylsulfonyl)amino]-1-\{[2-(pyrrolidin-1-ylmethyl)-1,3-oxazol-4-yl]carbonyl\}pyrrolidin-2-yl)butanoic acid	0
(4S)-2-\{2-[amino(4-hydroxyphenyl)methyl]-5-oxo-1,3-oxazol-4-ylidene\}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	0
1,3-oxazole	0
1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methylsulfinyl]ethanone	0
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfonyl]ethanone	0
1-[[2-(3-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-3-piperidinecarboxamide	0
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide	0
1-[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methyl]-N-[(2-methoxyphenyl)methyl]-4-piperidinecarboxamide	0
1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-N-(3-pyridinylmethyl)-4-piperidinecarboxamide	0
1-butyl-2-[(5-phenyl-2-oxazolyl)methylthio]-5-benzimidazolesulfonamide	0
2-(1-naphthalenyl)-N-(2-phenyl-1,3-benzoxazol-5-yl)acetamide	0
2-(2-chlorophenyl)-5-(2-methylpropylamino)-4-oxazolecarbonitrile	0
2-(2-chlorophenyl)-5-(methylamino)-4-oxazolecarbonitrile	0
2-(2-fluorophenyl)-4-(4-fluorophenyl)sulfonyl-5-(1-piperidinyl)oxazole	0
2-(2-fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile	0
2-(2-fluorophenyl)-5-(4-methyl-1-piperidinyl)-4-oxazolecarbonitrile	0
2-(2-methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile	0
2-(3-chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile	0
2-(4-bromophenoxy)-N-[3-(5-chloro-1,3-benzoxazol-2-yl)-2-methylphenyl]acetamide	0
2-(4-chlorophenyl)-5-(1-piperidinyl)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(2-oxolanylmethylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(methylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-[2-(2-pyridinyl)ethylamino]-4-oxazolecarbonitrile	0
2-(4-fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile	0
2-(4-methoxyphenyl)-5-(2-phenylethylamino)-4-oxazolecarbonitrile	0
2-(4-methylphenoxy)-N-[4-(2-oxazolo[4,5-b]pyridinyl)phenyl]acetamide	0
2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol	0
2-(p-nitrophenyl)-4-ethoxymethyleneoxazol-5-one	0
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide	0
2-[4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)phenyl]-1,3-benzoxazole	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-4-oxazolecarbonitrile	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-[3-(1-imidazolyl)propylamino]-4-oxazolecarbonitrile	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-[3-(1-pyrrolidinyl)propyl]acetamide	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-1-(4-ethyl-1-piperazinyl)ethanone	0
2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-N-(2-furanylmethyl)acetamide	0
2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-N-prop-2-ynylacetamide	0
2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]-N-(2-oxolanylmethyl)acetamide	0
2-[[5-methyl-2-[4-(methylthio)phenyl]-4-oxazolyl]methylthio]-1-(4-morpholinyl)ethanone	0
2-benzyl-4-hydroxymethylene-5-oxazolone	0
2-fluoro-N-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]benzamide	0
2-methyl-4-phenyl-5-pyridin-4-yloxazole	0
2-phenyloxazol-5(4H)-one	0
3-(5-phenyl-1,3-oxazol-2-yl)-4-(trifluoromethyl)pyridine	0
4,5-diphenyl-1,3-oxazole-2-thiol	0
4-(2-oxazolo[4,5-b]pyridinyl)aniline	0
4-(benzenesulfonyl)-5-(ethylthio)-2-phenyloxazole	0
4-(ethoxymethylene)-2-(2-furyl)oxazol-5-one	0
4-(ethoxymethylene)-2-phenyloxazol-5-one	338
4-(ethoxymethylene)-2-styryloxazol-5-one	0
4-[(4,5-diphenyl-2-oxazolyl)thio]-1-(4-nitrophenyl)butane-1,3-diol	0
4-[(5-oxo-2-phenyl-1,3-oxazol-4-ylidene)methylamino]but-2-enoic acid	0
4-[[5-methyl-2-[3-(trifluoromethyl)phenyl]-4-oxazolyl]methyl]morpholine	0
4-[[[1-[[2-(3-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-3-piperidinyl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester	0
5-(1-azepanyl)-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(2-methylphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(3-methylphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(4-methoxyphenyl)-4-oxazolecarbonitrile	0
5-(4-Methylphenyl)-1,3-oxazole	0
5-(4-fluorophenyl)-2-thiophen-2-yloxazole	0
5-(4-methoxyphenyl)-N-[(5-methyl-2-phenyl-4-triazolyl)methyl]-4-oxazolecarboxamide	0
5-(dimethylamino)-2-phenyl-4-oxazolecarbonitrile	0
5-Phenyl-1,3-oxazole	0
5-[(2-chlorophenyl)methylamino]-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile	0
5-[(2-chlorophenyl)methylamino]-2-(4-methoxyphenyl)-4-oxazolecarbonitrile	0
5-[(4-fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile	0
5-[3-(dimethylamino)propylamino]-2-(2-fluorophenyl)-4-oxazolecarbonitrile	0
5-bromo-N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-3-pyridinecarboxamide	0
5-nitro-2-phenyl-1,3-benzoxazole	0
5-phenyl-2-[([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)methyl]oxazole	0
6-methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-2-spiro[1H-3,1-benzoxazine-4,4'-piperidine]one	0
AJI9561	0
Caboxamycin	0
Condurangogenin A	0
DDM-838	0
DND-160 dye	0
Demethyl UK-1	0
GNF6702	0
Graphostrin A	0
Hinduchelin A	0
Hinduchelin B	0
Hinduchelin C	0
Hinduchelin D	0
JH-02215	0
Methylhalfordinol	0
Muraglitazar	478
N-(1,3-benzodioxol-5-ylmethyl)-2-[[2-(2-fluorophenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-(2,5-dimethoxyphenyl)-2-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methylsulfonyl]acetamide	0
N-(4,5-diphenyl-2-oxazolyl)-2-[(1-methyl-5-tetrazolyl)thio]acetamide	0
N-(4,5-diphenyl-2-oxazolyl)-3-methoxybenzamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide	0
N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]-1,3-benzodioxole-5-carboxamide	0
N-[2-[bis(2-methylpropyl)amino]ethyl]-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide	0
N-[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)phenyl]-2-phenoxyacetamide	0
N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-4-piperidinecarboxamide	0
N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-2-thiophen-2-ylacetamide	0
N-[3-(cyclohexylthio)propyl]-2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide	0
N-[3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]-2-[[4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]carbamic acid ethyl ester	0
N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide	0
N-[4-(5-chloro-1,3-benzoxazol-2-yl)phenyl]-2-oxolanecarboxamide	0
N-[4-[(2R,4R,6S)-4-[[(4,5-diphenyl-2-oxazolyl)thio]methyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N'-hydroxyoctanediamide	0
N-[5-(1,3-benzoxazol-2-yl)-2-methylphenyl]-2-phenoxyacetamide	0
N-cyclobutyl-2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[5-methyl-2-(4-propoxyphenyl)-4-oxazolyl]methylthio]acetamide	0
N-demethylindolmycin	0
Nataxazole	0
Nocarbenzoxazole A	0
Nocarbenzoxazole B	0
Nocarbenzoxazole C	0
Nocarbenzoxazole D	0
Nocarbenzoxazole E	0
Nocarbenzoxazole F	0
Nocarbenzoxazole G	0
O-Isopentenylhalfordinol	0
POPOP	0
Telomestatin	0
UK-1	0
YM-216391	0
azumolene	0
bistratamide I	0
cascade yellow	0
curacozole	0
dalfopristin	0
dapoxyl (2-aminoethyl)sulfonamide +	0
desferriexochelin 772MS +	0
desferrimycobactin T +	0
ditazole	0
formobactin	0
fura-2 dye	0
fura-2(5-) +	0
indolmycin	0
leucascandrolide A congener	0
levesquamide	0
martefragin A	0
oxaprozin	4
oxazoline +	0
pemoline	0
penicillenic acid +	0
pristinamycin IIA +	0
rhizoxin	0
tilmacoxib	0
venturamide A	0
venturamide B	0
vibriobactin +	0
Path 2
Term	Annotations
CHEBI ontology	19890
subatomic particle	19867
composite particle	19888
hadron	19888
baryon	19888
nucleon	19867
atomic nucleus	19888
atom	19888
main group element atom	19806
p-block element atom	19806
carbon group element atom	19746
carbon atom	19743
organic molecular entity	19743
organic molecule	19714
organic cyclic compound	19485
organic heterocyclic compound	18881
heteroarene	17148
monocyclic heteroarene	14977
azole	14500
oxazole	3646
1,3-oxazoles	797
(16alpha,20R,24R)-24N,25-carbamoyloxy-2,16,20-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside	0
(2S)-3-methyl-2-((2R,3S)-3-[(methylsulfonyl)amino]-1-\{[2-(pyrrolidin-1-ylmethyl)-1,3-oxazol-4-yl]carbonyl\}pyrrolidin-2-yl)butanoic acid	0
(4S)-2-\{2-[amino(4-hydroxyphenyl)methyl]-5-oxo-1,3-oxazol-4-ylidene\}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	0
1,3-oxazole	0
1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methylsulfinyl]ethanone	0
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfonyl]ethanone	0
1-[[2-(3-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-3-piperidinecarboxamide	0
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide	0
1-[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methyl]-N-[(2-methoxyphenyl)methyl]-4-piperidinecarboxamide	0
1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-N-(3-pyridinylmethyl)-4-piperidinecarboxamide	0
1-butyl-2-[(5-phenyl-2-oxazolyl)methylthio]-5-benzimidazolesulfonamide	0
2-(1-naphthalenyl)-N-(2-phenyl-1,3-benzoxazol-5-yl)acetamide	0
2-(2-chlorophenyl)-5-(2-methylpropylamino)-4-oxazolecarbonitrile	0
2-(2-chlorophenyl)-5-(methylamino)-4-oxazolecarbonitrile	0
2-(2-fluorophenyl)-4-(4-fluorophenyl)sulfonyl-5-(1-piperidinyl)oxazole	0
2-(2-fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile	0
2-(2-fluorophenyl)-5-(4-methyl-1-piperidinyl)-4-oxazolecarbonitrile	0
2-(2-methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile	0
2-(3-chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile	0
2-(4-bromophenoxy)-N-[3-(5-chloro-1,3-benzoxazol-2-yl)-2-methylphenyl]acetamide	0
2-(4-chlorophenyl)-5-(1-piperidinyl)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(2-oxolanylmethylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(methylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile	0
2-(4-chlorophenyl)-5-[2-(2-pyridinyl)ethylamino]-4-oxazolecarbonitrile	0
2-(4-fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile	0
2-(4-methoxyphenyl)-5-(2-phenylethylamino)-4-oxazolecarbonitrile	0
2-(4-methylphenoxy)-N-[4-(2-oxazolo[4,5-b]pyridinyl)phenyl]acetamide	0
2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol	0
2-(p-nitrophenyl)-4-ethoxymethyleneoxazol-5-one	0
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide	0
2-[4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)phenyl]-1,3-benzoxazole	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-4-oxazolecarbonitrile	0
2-[4-[(4-chlorophenyl)methoxy]phenyl]-5-[3-(1-imidazolyl)propylamino]-4-oxazolecarbonitrile	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-[3-(1-pyrrolidinyl)propyl]acetamide	0
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-1-(4-ethyl-1-piperazinyl)ethanone	0
2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-N-(2-furanylmethyl)acetamide	0
2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-N-prop-2-ynylacetamide	0
2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]-N-(2-oxolanylmethyl)acetamide	0
2-[[5-methyl-2-[4-(methylthio)phenyl]-4-oxazolyl]methylthio]-1-(4-morpholinyl)ethanone	0
2-benzyl-4-hydroxymethylene-5-oxazolone	0
2-fluoro-N-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]benzamide	0
2-methyl-4-phenyl-5-pyridin-4-yloxazole	0
2-phenyloxazol-5(4H)-one	0
3-(5-phenyl-1,3-oxazol-2-yl)-4-(trifluoromethyl)pyridine	0
4,5-diphenyl-1,3-oxazole-2-thiol	0
4-(2-oxazolo[4,5-b]pyridinyl)aniline	0
4-(benzenesulfonyl)-5-(ethylthio)-2-phenyloxazole	0
4-(ethoxymethylene)-2-(2-furyl)oxazol-5-one	0
4-(ethoxymethylene)-2-phenyloxazol-5-one	338
4-(ethoxymethylene)-2-styryloxazol-5-one	0
4-[(4,5-diphenyl-2-oxazolyl)thio]-1-(4-nitrophenyl)butane-1,3-diol	0
4-[(5-oxo-2-phenyl-1,3-oxazol-4-ylidene)methylamino]but-2-enoic acid	0
4-[[5-methyl-2-[3-(trifluoromethyl)phenyl]-4-oxazolyl]methyl]morpholine	0
4-[[[1-[[2-(3-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-3-piperidinyl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester	0
5-(1-azepanyl)-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(2-methylphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(3-methylphenyl)-4-oxazolecarbonitrile	0
5-(2-furanylmethylamino)-2-(4-methoxyphenyl)-4-oxazolecarbonitrile	0
5-(4-Methylphenyl)-1,3-oxazole	0
5-(4-fluorophenyl)-2-thiophen-2-yloxazole	0
5-(4-methoxyphenyl)-N-[(5-methyl-2-phenyl-4-triazolyl)methyl]-4-oxazolecarboxamide	0
5-(dimethylamino)-2-phenyl-4-oxazolecarbonitrile	0
5-Phenyl-1,3-oxazole	0
5-[(2-chlorophenyl)methylamino]-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile	0
5-[(2-chlorophenyl)methylamino]-2-(4-methoxyphenyl)-4-oxazolecarbonitrile	0
5-[(4-fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile	0
5-[3-(dimethylamino)propylamino]-2-(2-fluorophenyl)-4-oxazolecarbonitrile	0
5-bromo-N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-3-pyridinecarboxamide	0
5-nitro-2-phenyl-1,3-benzoxazole	0
5-phenyl-2-[([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)methyl]oxazole	0
6-methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-2-spiro[1H-3,1-benzoxazine-4,4'-piperidine]one	0
AJI9561	0
Caboxamycin	0
Condurangogenin A	0
DDM-838	0
DND-160 dye	0
Demethyl UK-1	0
GNF6702	0
Graphostrin A	0
Hinduchelin A	0
Hinduchelin B	0
Hinduchelin C	0
Hinduchelin D	0
JH-02215	0
Methylhalfordinol	0
Muraglitazar	478
N-(1,3-benzodioxol-5-ylmethyl)-2-[[2-(2-fluorophenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-(2,5-dimethoxyphenyl)-2-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methylsulfonyl]acetamide	0
N-(4,5-diphenyl-2-oxazolyl)-2-[(1-methyl-5-tetrazolyl)thio]acetamide	0
N-(4,5-diphenyl-2-oxazolyl)-3-methoxybenzamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide	0
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide	0
N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]-1,3-benzodioxole-5-carboxamide	0
N-[2-[bis(2-methylpropyl)amino]ethyl]-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide	0
N-[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)phenyl]-2-phenoxyacetamide	0
N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-[[5-methyl-2-(2-methylphenyl)-4-oxazolyl]methyl]-4-piperidinecarboxamide	0
N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-2-thiophen-2-ylacetamide	0
N-[3-(cyclohexylthio)propyl]-2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide	0
N-[3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]-2-[[4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]carbamic acid ethyl ester	0
N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide	0
N-[4-(5-chloro-1,3-benzoxazol-2-yl)phenyl]-2-oxolanecarboxamide	0
N-[4-[(2R,4R,6S)-4-[[(4,5-diphenyl-2-oxazolyl)thio]methyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N'-hydroxyoctanediamide	0
N-[5-(1,3-benzoxazol-2-yl)-2-methylphenyl]-2-phenoxyacetamide	0
N-cyclobutyl-2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[2-(4-ethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methylthio]acetamide	0
N-cyclopropyl-2-[[5-methyl-2-(4-propoxyphenyl)-4-oxazolyl]methylthio]acetamide	0
N-demethylindolmycin	0
Nataxazole	0
Nocarbenzoxazole A	0
Nocarbenzoxazole B	0
Nocarbenzoxazole C	0
Nocarbenzoxazole D	0
Nocarbenzoxazole E	0
Nocarbenzoxazole F	0
Nocarbenzoxazole G	0
O-Isopentenylhalfordinol	0
POPOP	0
Telomestatin	0
UK-1	0
YM-216391	0
azumolene	0
bistratamide I	0
cascade yellow	0
curacozole	0
dalfopristin	0
dapoxyl (2-aminoethyl)sulfonamide +	0
desferriexochelin 772MS +	0
desferrimycobactin T +	0
ditazole	0
formobactin	0
fura-2 dye	0
fura-2(5-) +	0
indolmycin	0
leucascandrolide A congener	0
levesquamide	0
martefragin A	0
oxaprozin	4
oxazoline +	0
pemoline	0
penicillenic acid +	0
pristinamycin IIA +	0
rhizoxin	0
tilmacoxib	0
venturamide A	0
venturamide B	0
vibriobactin +	0

paths to the root